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Abstract 
Chromatin architecture is an important regulator of gene expression, which dictates 
development. Mutations in one copy of the CTCF chromatin organizer gene cause 
intellectual disability and autism. Polymorphisms in CTCF have also been associated with 
increased risk for schizophrenia, a condition that overlaps in biological etiology with autism 
and intellectual disability. In this thesis, we sought to understand the role of CTCF in 
neurodevelopment using brain-specific conditional knockout and heterozygote mouse 
models. Using the Ctcf-null animals, we identify a cell-autonomous role for CTCF in 
regulating cortical interneuron development in the medial ganglionic eminence (MGE) 
through the transcriptional control of Lhx6. In the absence of CTCF, MGE-derived cortical 
interneuron subtypes are inappropriately specified such that their cortical laminar position is 
altered and there is a reduction in the number of cells expressing PV and SST. These features 
are rescued with viral-mediated re-expression of Lhx6. In addition, there is a concomitant 
increase in the expression of Lhx8, which specifies ventral telencephalic cell types in the 
MGE, indicating CTCF is an important regulator of cell fate choice in the MGE. To model 
the human condition associated with CTCF mutation, we generated mice heterozygous for 
Ctcf deletion in the developing brain (CtcfNestinHet). These mice had spontaneous hyperactivity 
and impaired spatial learning on behavioural testing. In addition to these behaviours, male 
mice had decreased sociability, altered aggression, and decreased anxiety. Together, this 
constellation of behaviours is reminiscent of other mouse models of schizophrenia, autism 
and intellectual disability. In addition, structural MRI revealed that CtcfNestinHet mouse brains 
had decreased white matter volume, suggestive of hypoconnectivity, a feature commonly 
attributed to the pathophysiology of autism. There were also significant volume decreases in 
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the cerebellar nuclei, and an increase in the anterior cerebellar lobe. These findings provide 
further evidence for the emerging role of the cerebellum in cognition and in 
neurodevelopmental disorders. In summary, this work addresses the consequence of reduced 
CTCF expression in the developing brain at cellular, structural and behaviour levels, and thus 
significantly furthers our understanding of chromatin architecture regulation in 
neurodevelopmental disease.       
Words: 338  
Keywords 
CTCF, chromatin organization, Autism Spectrum Disorder, Intellectual Disability, 
schizophrenia, epigenetics, medial ganglionic eminence, cortical interneurons, mouse model 
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Epigraph 
“What is it that we rat runners [psychologists who work with rats] still have to contribute to 
the understanding of the deeds and misdeeds, the absurdities and the tragedies of our friend, 
and our enemy-homo sapiens? The answer is that, whereas man’s successes, persistences, 
and socially unacceptable divagations—that is, his intelligences, his motivations, and his 
instabilities—are all ultimately shaped and materialised by specific cultures, it is still true 
that most of the formal underlying laws of intelligence, motivation, and instability can still be 
studied in rats as well as, and more easily than, in men.” 
E.C. Tolman (1945) 
 
"P.S. please if you get a chance put some flowers on Algernon's grave in the back yard."  
Daniel Keyes, Flowers for Algernon 
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1 Introduction 
1.1 Brain Development 
1.1.1 General overview 
Early processes in brain patterning are conserved among vertebrates (reviewed in 1,2). The 
nervous system is derived from the ectoderm by inhibition of BMP/TGF-beta signalling 
(reviewed in 3). Through the process of neurulation, the neuro-ectoderm forms a hollow 
tube that divides into three major parts, the forebrain (prosencephalon), midbrain 
(mesencephalon) and the hindbrain (rhombencephalon), with a central fluid-filled 
ventricular system. The forebrain is further subdivided into the telencephalon and 
diencephalon. The cerebral cortex, which is responsible for higher functions such as 
thought and language in humans, is a large part of the mature telencephalon. The 
hippocampi (involved in memory formation) and basal ganglia (which function in 
voluntary movement) are also located in the telencephalon.  
The brain consists of neurons and non-neuronal cells called glia. Neurons are a 
heterogeneous group of electrically-responsive cells that receive and transmit electrical and 
chemical information. They have specialized cellular structure for this function: the soma 
is the cell body, which houses the nucleus; the dendrites are branched extensions that 
receive signal from another neuron and transmit it to the soma; and the axon which is a 
slender projection that typically transmits signal away from the cell body. In addition, the 
dendrites can harbour hundreds of spines that function in synaptic transmission. 
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The telencephalon is the most diverse brain region with respect to neuronal variety4. Part 
of this diversity results from early molecular signals that induce and maintain anterior-
posterior and dorso-ventral patterning in the telencephalon1,3–5, summarized in Figure 1. 
All neurons are generated from progenitors of specific positional identity, which then 
migrate to their final position in the mature brain and form the appropriate connections to 
integrate into functional networks. The final position and functional identity of the mature 
neuron is based on intrinsic and extrinsic factors. Fate-mapping experiments in vivo 
through cell-labeling, historically through [3H] thymidine and then by genetic means, have 
revealed the origins and movements of neuron subtypes.  
1.1.2 Cortical excitatory neurons 
The cerebral cortex contains a large variety of excitatory neurons (pyramidal and 
projection) that release the excitatory neurotransmitter glutamate. Cortical excitatory 
neurons are generated from dorsal progenitors known as radial glia cells (RGC), typically 
situated in the ventricular zone (VZ), and intermediate progenitors in the subventricular 
zone (SVZ) (reviewed in 6,7) between gestational week 5 and 20 (humans) and embryonic 
day (E) 11 to 19 (mice) (reviewed in 6). Symmetric division of RGC results in self-renewal 
of these progenitors, and has been implicated in determining final brain size5,8. Retinoic 
acid signalling induces a switch of RGC to asymmetric, neurogenic divisions. Recently, a 
subtype of RGC, outer radial glia, that loses the apical process and moves out of the VZ, 
was also described. Outer radial glia are present in mice, but exist in greater number in the 
primate cortex. Asymmetric RGC divisions generate one daughter cell identical to the 
parent cell, and another daughter cell that is an excitatory neuron or an intermediate 
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progenitor (reviewed in 8,9). Intermediate progenitors typically undergo one division to 
produce two excitatory neurons.  
 
Figure 1: Overview of brain development in mice.  
(A) Transverse image of the mesoderm-derived (pink) notochord, which induces 
neurulation (purple) in the overlying ectoderm (blue). This occurs through the inhibition 
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of TGF-beta / BMP signalling. Some of the implicated molecules include SIP1, SMAD7, 
and Noggin. The neuroectoderm (purple), also called the neural plate, invaginates and the 
centre hollows to form the neural tube (secondary neurulation), from which forms the 
future brain and spinal cord. (B) Sagittal view of the neural tube, which becomes specified 
from rostral to caudal as forebrain (telencephalon & diencephalon), midbrain, hindbrain, 
and spinal cord. Organizers, such as the zona limitans intrathalamica (diencephalon) and 
the isthmus (midbrain-hindbrain junction) secrete morphogens to create boundaries 
between developing brain regions. The zona limitans intrathalamica is a strong source of 
SHH (yellow), while the isthmus secretes the dorsalizing morphogen FGF8 (turquoise). 
Other dorsalizing signals include Retinoic Acid, other FGFs, and WNT. Anterior fate is 
generated in the absence of dorsalizing signals. Also, the head does not form without 
influence of the anterior-lying anterior visceral endoderm (AVE) which expresses Otx2 
and Lhx1, among other transcription factors. The floor or basal plate of the neural tube 
expresses the diffusible morphogen SHH (yellow), the major ventralizing signal in the 
neural tube. Nkx2.2 (red) expression is induced at high concentrations of SHH, and creates 
the alar-basal boundary from the hindbrain to the diencephalon. (C) Sagittal view of the 
embryonic brain (E13.5). Different shades of purple correspond to forebrain, midbrain, and 
hindbrain. Black lines indicate the two levels at which coronal sections are shown in (D) 
and (E). (D) Rostral coronal section through the embryonic (E13.5) mouse telencephalon, 
depicting the POA, MGE and LGE on both sides. NKX2.1 expression (orange) is located 
in the MGE (depicted only on one half for simplicity), and in the striatum, to where MGE-
cells have begun to migrate by E13.5. The arrow indicates the path of tangential migration 
of MGE cells destined to the cortex. (E) Caudal coronal section through the embryonic 
(E13.5) mouse telencephalon, depicting the CGE. The arrow indicates the path of 
tangential migration of CGE cells to the cortex. (F) Sagittal view of the adult murine brain 
coloured different shades of purple to indicate the forebrain, midbrain and hindbrain. Some 
major structures are indicated. OB= olfactory bulb, Hip= hippocampus. Adapted from 
Puelles and Rubenstein 20151. 
 
With the exception of the olfactory cortex and part of the temporal lobe, the human cerebral 
cortex is organized into six functionally and anatomically distinct layers of excitatory 
neurons. The layers are generated such that layer VI is closest to the SVZ, and is formed 
first. Successive layers of excitatory neurons are formed in an inside-out manner by tightly 
controlled progenitor divisions and radial migration of daughter-cells (reviewed in 6). Not 
only do RGCs act as progenitors, but their basal processes also form a scaffold for the 
migration of excitatory neurons. Migration is guided, therefore, by interactions with the 
radial glial process, along with other intrinsic and extrinsic factors10. One such extrinsic 
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factor is REELIN (RLN), a glycoprotein secreted by the Cajal-Retzius cells in the marginal 
zone (layer I) (reviewed in 5,11).  
Transplant experiments indicate that layer identity of the neuron is determined at the level 
of the progenitor cell, which responds to extrinsic cues to generate the neuron subtype for 
the appropriate developmental age (reviewed in 9). Moreover, retroviral-labeling 
experiments suggest the existence of two different progenitor populations, one generating 
layers II-IV, and the other V-VI, and this remains incompletely understood6. One proposed 
explanation is the coexistence of both multipotent and restricted progenitors.   
The vast majority of excitatory neurons (reviewed in 6,9) are pyramidal neurons, 
characterized by their single long apical dendrite. Pyramidal neurons are found in all 
cortical layers except layer I. In contrast, spiny stellate neurons are a locally-connecting 
excitatory neuron with several dendrites of similar lengths. Spiny stellate neurons are 
specialized in receiving the majority of thalamic inputs and are found exclusively in layer 
IV. The majority of locally targeting pyramidal neurons are located in layers II and III. 
Some pyramidal neurons can be sub-classified as projection neurons if they connect i) to 
distant cortex (associative or commissural projection neurons), or ii) to non-cortical brain 
regions (corticofugal projection neurons). Commissural projection neurons connect via 
either the corpus callosum or the anterior commissure. Cortifugal projection neurons 
(reviewed in 12) can be sub-divided by hodology, into i) corticothalamic (layer VI), ii) 
corticopontine, corticospinal, and corticotectal (layer V), and ii) corticostriatal neurons. 
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1.1.3 Cortical inhibitory neurons 
The second major class of cortical neurons are inhibitory neurons that release gamma-
aminobutyric acid (GABA), which is the main inhibitory neurotransmitter of the adult 
brain.  They comprise 20-30% of cortical neurons in primates13 and 10-15% in rodents14. 
In the adult mammalian brain, GABAergic cells are identified by the expression of two 
isoforms of glutamate decarboxylases (GAD), GAD 67 or 65, expressed from Gad1 and 
Gad2 genes, respectively. They are also called interneurons as they form local connections, 
where there role is to gate signal flow, shape and synchronize network outputs, and 
generate cortical rhythms15.  
Many different subtypes of cortical interneurons exist, but there is currently no consensus 
on a formal classification system15. Cortical interneurons can be classified by marker 
expression, firing properties, and morphology (Figure 2). Morphologically, they can be 
grouped by the laminar position of their soma, and shape of their dendrites and axon, and 
can even be described by the preferred targeted subcellular domain of their axons (ie soma, 
dendrite or axon)15. Electro-physiologically, firing capacity can vary due to differences in 
processing of signals from other cells, including other interneurons through different 
GABA receptor subunit expression16. In terms of markers, nearly 100% of Gad1-
expressing cells in the cortex can be captured by staining for the markers somatostatin 
(Sst), Parvalbumin (Pv), and serotonin receptor (5HT3aR)17,18 (reviewed in 15). In the past, 
Calretinin (Cr) has also been used with Sst and Pv to classify nearly all cortical 
interneurons, albeit both Cr and 5HT3aR have some overlap with Sst19.   
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Figure 2: Summary of interneuron subtype classification characteristics.  
 
Adapted from Tremblay, et al. 2016; and morphology images from Themes, 2016.   
1. Tremblay, R., Lee, S. & Rudy, B. GABAergic Interneurons in the Neocortex:  From 
Cellular Properties to Circuits. Neuron 91, 260–292 (2016). 
2. Themes, U. F. O. Neocortical Anatomy and Physiology. Neupsy Key (2016). 
 
Unlike the excitatory neurons of the cortex, which are generated in situ, the interneurons 
are generated outside of the future neocortex. Cortical interneurons are generated from 
neuroprogenitors in the ventral telencephalon, and then migrate tangentially into the 
forming cortical layers during development. In rodents, they are generated in the preoptic 
area (POA), and transient embryonic structures known as the medial ganglionic eminence 
(MGE) and the caudal ganglionic eminence (CGE), between E12-1420 (Figure 1). In 
humans, there is some evidence that cortical radial glia have the potential to generate 
GABAergic neurons21, however the vast majority of interneurons are also produced in the 
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VZ and SVZ of ganglionic eminences, rather than from the cortex, and many are derived 
from a non-epithelial neural stem cell in the SVZ, during the early second trimester (weeks 
8 to 14)22. The MGE produces the majority (approximately 70%) of the cortical 
interneurons in rodents23 (reviewed in20). In contrast, it appears that the majority of human 
cortical interneurons are generated in the CGE rather than the MGE22.  The POA in mice 
contributes to less than 10% of interneurons24.  
Early specification of interneurons 
As a class, cortical interneurons can be recognized in the cortex by early expression (E10.5) 
of the Distal-less homebox (Dlx) genes, which are arranged in bigenic clusters, and drive 
expression of Gad1/2, required for GABA production25,26. Dlx genes are also expressed in 
GABAergic projection neurons in the ventral forebrain discussed in a later section.  Dlx1/2 
appear to be required for early differentiation, as they are already expressed in the VZ and 
SVZ of the ganglionic eminences, whereas Dlx5/6 are turned on in the migrating 
interneurons27. Inactivation of both Dlx1/2 is perinatal lethal, and results in a failure of 
cortical interneurons to migrate tangentially to the cortex28. The neurons stay as ectopia in 
the basal ganglia, resulting in a 75% reduction of interneurons in the cortex28,29. In these 
double-knockout mice, Dlx5/6 expression is also reduced28, most likely due to their failed 
activation by DLX2, which binds at the intergenic enhancer, I56i30. Dlx1/2 have at least 
two intergenic regulatory elements, I12a and I12b31,32. The migratory function associated 
with Dlx1/2 is thought to be regulated in part due to DLX2 activation of Aristaless related 
homeobox (Arx). ARX is expressed in tangentially migrating cortical interneurons and 
activates the expression of cell surface receptors implicated in interneuron migration, 
including C-X-C chemokine receptor type 4 (CXCR4)33,34. 
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CGE-derived cortical interneurons 
The CGE consists of two subdomains: the ventral CGE is the caudal extension of the MGE 
and the dorsal part is an extension of the lateral ganglionic eminence (LGE)29,35 (Figure 1). 
The CGE can however be distinguished from both the MGE and LGE by marker 
expression, such as COUP-TFII29,36,37. The cortical interneurons derived from the CGE 
have a distinct pattern of tangential migration, preferentially contribute to different cortical 
laminar positions, and have different marker expression36.  Transplant experiments suggest 
these features are intrinsic, rather than induced by local cues, suggesting that the CGE is 
more than just an extension of other structures, but represents a unique group of progenitors 
with diverse potential36.  
All CGE-derived cortical interneurons express 5HT3aR18. These can be further divided 
into those that express Vasointestinal peptide (Vip) and those that do not. About 40% of 
the 5HT3aR subtype of interneurons express Vip, and there is no overlap between Vip and 
Pv or Sst18. About 27% of E13.5 CGE cells go on to express Sst, whereas less than 3% 
have detectable Pv expression36. Other markers expressed by a large portion of CGE-
derived interneurons are Cr, Rln, Prox1 and Sp838. Morphologically, CGE-derived 
interneurons can have radially-oriented processes, multipolar-shape, or neurogliaform 
shape18. CGE-derived cortical interneurons can occupy any laminar position, but are 
preferentially positioned in more superficial layers36,39.  
In terms of their migration, CGE-derived interneurons tend to migrate into the cortex later 
than those from the MGE38. The ability of CGE-derived interneurons to tangentially 
migrate along the posterior cortex is in part due to COUP-TFII expression37. In addition, 
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CGE-derived interneurons were found to travel along two novel other caudo-rostral 
streams, one laterally towards the LGE (requiring COUP-TFI expression), and one 
medially towards the POA38. 
MGE-derived cortical interneurons 
The MGE is a source of cortical interneurons, striatal neurons, globus pallidus cells, 
amygdala cells, oligodendrocytes, and to a lesser extent, hippocampal 
interneurons29,36,40,41. Specification of the MGE is dependent on the expression of NKX2.1 
which is detectable in the telencephalon from approximately E9.542. NKX2.1 is present in 
the proliferating cells of the MGE and its expression depends on sonic hedgehog (SHH) 
signalling43. Homozygous targeted deletion of Nkx2.1 in mice results in perinatal death, 
and although an MGE-like structure forms, it appears to be re-specified to LGE fate, which 
generates GABAergic medium spiny neurons destined for the striatum44. Therefore, in 
Nkx2.1 mutant mice, the early migrating MGE-derived cortical interneurons are not 
generated, whereas the late-migrating CGE-derived cortical interneurons are 
unaffected44,45. 
The function of NKX2.1 was further studied by its conditional deletion at E10.5, and at 
E12.5, which allows the initial formation of the MGE46. Under both conditions, the authors 
observed that the cortical interneurons generated from the MGE were re-specified to CGE-
like cortical interneurons. For example, the neurons preferentially expressed CGE markers 
VIP and CR at the expense of PV and SST, and had firing patterns of late-spiking 
neurogliaform-type interneurons. In addition, earlier deletion of Nkx2.1 reproduced 
previous work; there was a reduction in total cortical interneuron numbers and a 
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concomitant increase in the generation of LGE-type, GABAergic medium spiny neurons 
destined for the striatum. These results highlight the dual function of NKX2.1 as i) 
specifying MGE versus LGE fate in early forebrain cells, and ii) specifying PV and SST 
interneuron subtypes over the seemingly default CGE-like subtypes later in development. 
This second role of NKX2.1 was eventually shown to be due to the downstream activation 
of the LIM homeodomain transcription factor LHX647, discussed in detail below.  As cells 
exit the cell cycle and reposition in the SVZ of the MGE, NKX2.1 directly induces the 
expression of Lhx635,48, through binding to a site 240 bases upstream of the transcription 
start site49. The immature Lhx6-expressing neurons of the MGE SVZ produce GABA40,48 
and are referred to as proto-GABAergic neurons. 
Counter-intuitively, down-regulation of Nkx2.1 is required in post-mitotic LHX6-positive 
MGE-derived cells for their migration to the cortex50. The ectopic expression of NKX2.1 
in these cells leads to their accumulation in the striatum. The cortical interneurons from the 
MGE were shown to express Neuropilin-1 and 2, receptors for the migratory-repellents 
semaphorin-3A and F, respectively, present in the developing striatum51. NKX2.1 inhibits 
the expression of Neuropilin transcripts, and therefore its down-regulation in MGE-derived 
cortical interneurons is required for their avoidance of the striatum and continued tangential 
migration into the neocortex50. In addition to semaphorins, MGE-derived cells destined for 
the cortex are guided through a ventral permissive corridor by ERBB4/ neuregulin-1 
(NRGN1) signalling52.  
As mentioned above, deletion of Nkx2.1 specifically results in a loss of PV and SST cortical 
interneuron subtypes. Du et al.49 performed elegant experiments in which electroporation 
of Nkx2.1 or Lhx6 cDNA into Nkx2.1-null cultured embryonic brain slices, followed by 
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transplantation into wildtype neocortex, rescued the number of SST and PV positive 
interneurons.  As expected, Lhx6 mutant animals also do not produce PV and SST cortical 
interneuron subtypes48,53. PV-expressing cortical interneurons are typically described as 
Chandelier cells (also called axo-axonic) and Basket cells (the majority of which are fast-
spiking). This fast-spiking property allows PV-positive interneurons to contribute to 
synchronizing excitatory neuron firing into gamma oscillatory waves15,54. SST-expressing 
interneurons are typically categorized as Martinotti cells and bitufted cells15. 
Lhx6-null MGE cells appear to lose the ability to become PV and SST subtypes, while 
acquiring a CGE-like fate47. Electro-physiologically, Lhx6-null MGE cells were no longer 
fast-spiking, but instead had late-spiking properties of neurogliaform interneurons. In 
addition, there was an increase in the expression of CGE-cell marker SP8, and a preference 
to laminate to superficial cortical layers, especially layer I.       
In addition, LHX6 was shown to bind and activate the Arx and Cxcr7 genes involved in 
interneuron migration47. Transduction of Lhx6-null cells with Arx cDNA partially rescued 
the expression of PV and SST, but did not significantly alter the number of Lhx6-null cells 
that ended up ectopically in layer I of the cortex. Alternatively, transduction with Cxcr7 
cDNA partially rescued the lamination defect but not PV or SST expression, suggesting 
these downstream effectors of LHX6 are required for different downstream functions.  
1.1.4 Ventral forebrain cells specified by the MGE  
The MGE-derived cells that are destined to remain in the ventral forebrain maintain the 
expression of NKX2.1 to become striatal cholinergic and GABAergic interneurons, as well 
as GABAergic projection neurons of the basal forebrain55. Cholinergic neurons release 
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acetylcholine and are identified by the expression of the rate limiting enzyme in its 
synthesis, choline acetyl transferase (ChAT). These cholinergic and GABAergic 
interneurons of the striatum were shown to mature from the proto-GABAergic neurons41. 
The specification to cholinergic versus GABAergic fate was shown to depend on the 
combinatorial expression of LHX6, and two other LIM homeodomain transcription factors, 
ISLET-1 (ISL1) and LHX841.   
Like LHX6, LHX8 is also induced in post-mitotic cells of the MGE SVZ. However, LHX8 
is down-regulated in MGE-derived cells destined for the cortex. The MGE cells that 
maintain dual expression of LHX6 and LHX8 migrate tangentially and become the 
GABAergic striatal interneurons, which constitute approximately 1-2% of striatal 
neurons41. In contrast, some of the proto-GABAergic neurons down-regulate Lhx6 and 
maintain the expression of LHX8 and ISL1, specifying these cells to the cholinergic fate, 
constituting approximately 0.3% of the striatal neurons41. Interestingly, when Lhx8 was 
deleted, there was a reduction in cholinergic forebrain interneurons in exchange for an 
increased number of GABAergic striatal interneurons expressing LHX641,56. Another 
transcription factor, gastrulation brain homeobox 2 (GBX2), functions downstream of 
LHX8, and is required for the specification of the cholinergic striatal interneurons57. 
Despite the seemingly oppositional roles of LHX6 and LHX8 in specifying GABAergic 
versus cholinergic fate, there is evidence that these transcription factors have overlapping 
function. For example, when Lhx6-null MGE cells are transduced with ectopic Lhx8 cDNA 
before transplantation into the cortex, this partially rescues PV and SST expression, as well 
as cortical lamination defects47.  
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In addition, Lhx8 mutant mice not only had a loss of cholinergic interneurons, but also had 
a loss of basal forebrain projection neurons, which are non-cholinergic, and typically 
GABAergic58. The cells destined to become basal forebrain projection neurons migrate 
radially from the MGE and require not only LHX8, but also GBX2 expression57.  
1.2 Chromatin structure and CTCF 
1.2.1 Basics of chromatin  
In the eukaryotic cell, DNA is organized with associated proteins, and this complex is 
referred to as chromatin. The organization of DNA is dependent on the dynamic nature and 
modification of these proteins, termed chromatin remodeling, which in turn governs 
virtually all cellular function through precise regulation of gene expression59.  
The basic unit of DNA organization is known as the nucleosome, in which the 
negatively-charged linear DNA is tightly packaged with four pairs of positively-charged 
histones60. In the canonical nucleosome these four histones are H2A, H2B, H3 and H4, 
but these can be replaced by others in specific contexts (reviewed in 61). 
Histone H1 coats the so-called “linker DNA” between adjacent nucleosomes, and 
stabilizes the next levels of chromatin folding. The nucleosome-wrapped DNA is then 
thought to coil on itself into a 30 nm wide fiber, which can then be folded and looped into 
higher order tertiary structures. Epigenetics refers to the molecular determinants 
influencing chromatin structure, and this includes DNA methylation, nucleosome 
composition, histone post-translational modifications (PTM), and any non-coding RNAs 
and protein factors that regulate these.  
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Methylation of cytosine residues in DNA occurs through methyltransferases, and high 
levels of 5-methylcytosine residues are correlated with gene silencing (reviewed in 62). 
However, DNA methylation also occurs in exons of actively transcribed genes, and is 
thought to influence mRNA splicing63.  There are also in vivo derivatives of 5-
methylcytosine with unknown function; 5-formylcytosine, 5-carboxylcytosine, and 5-
hydroxymethylcytosine. In particular 5-hydroxymethylcytosine may be relevant to brain 
function, as it is enriched at intron-exon boundaries of genes encoding synapse proteins64. 
Histone PTM occurs at the N-terminal tails, which protrude from the nucleosome, and is 
an essential epigenetic mechanisms of gene regulation (reviewed in 65). PTM include, but 
are not limited to, methylation, acetylation, ubiquitination and phosphorylation. For 
example, histone acetylation is dynamically introduced and erased by histone 
acetyltransferases (HAT) and histone deacetylases (HDAC), respectively. These PTM are 
recognized by “reader” proteins and complexes that can execute further changes to 
chromatin organization.   
Many studies have attempted to decode the language of histone PTM (the histone code), 
and there has been some consensus in this realm. Acetylation of lysine residues (in 
particular at H3K9, H3K14) is associated with accessible, active genes (euchromatin)65. 
Trimethylation at H3K4 also tends to mark promoters of active genes66, whereas H3K9 
and H3K27 trimethylation are associated with repressed genes (reviewed in 67). Recently, 
attempts have been made to direct functional states of chromatin through the synthesis of 
defined, modified histones in order to better interrogate the role of specific PTM in 
chromatin regulation (reviewed in 68). However, there appears to be exceptions to every 
rule, and the so-called histone code is elaborate and cell-context dependent, with the 
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significance of different combination of PTM still being a topic of research, and the 
number of novel PTM still growing (reviewed in 69).         
The readers of PTM are often associated with ATPase function to allow for ATP-
dependent remodeling of chromatin at the target site. One of the functions of ATP-
dependent chromatin remodelers (reviewed in 70) is to displace nucleosomes to expose 
DNA sequences to DNA binding factors. 
Higher order chromatin structure refers to the three-dimensional, looped organization of 
the chromatin in the nucleus. The techniques of fluorescent in situ hybridization (FISH), 
chromosome conformation capture (3C), and techniques derived from 3C (reviewed in 71) 
have allowed scientists to begin to characterize higher order chromatin structure, and 
understand the factors that regulate it. Ubiquitous factors such as the mediator complex 
(MED), CCCTC-binding factor (CTCF, discussed in next section), and a complex of 
proteins called cohesin, have been implicated in loop formation (reviewed in 72). MED is 
a complex of up to 26 subunits that is involved in gene activation, and can mediate loop 
structure formation through interacting simultaneously with multiple proteins at different, 
distant chromatin sites72. Cohesin is a ring-shaped complex of proteins that was originally 
characterized for its role in sister chromatid cohesion during mitosis and meiosis and 
double-strand DNA break repair (reviewed in 73). The cohesin complex is thought to 
stabilize loop structures by encircling chromatin strands74. The ring shape is formed by 
SMC1, SMC3, and RAD21, whereas SA1/2 interacts with RAD21 to target cohesin to 
appropriate genomic sites (reviewed in 73).   
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Although incompletely understood, Hi-C experiments have shown that chromosomes are 
further compartmentalized into topologically associating domains (TAD), which are 
regions of chromatin with distinct epigenetic signatures that are characterized by a high 
number of intra-domain interactions75. Intra-domain chromatin loops allow for 
communication between promoters and enhancers that may be hundreds of kilobases apart. 
TAD boundaries represent transitions between differing epigenetic signatures, and are 
marked by insulator sequences bound by cohesin and CTCF76. Many aspects of TADs are 
concordant across multiple cell types, and even shared between human and mouse77.  
1.2.2 CTCF regulates chromatin higher order structure and gene expression 
CTCF is a highly conserved, ubiquitously expressed, eleven zinc finger protein that has 
multiple functions (reviewed in 78,79). The mammalian CTCF coding sequence is nearly 
identical to that of chicken (93% shared amino-acids), indicating conservation of protein 
structure, and likely function, over the past 300 million years (reviewed in 80). In the 
mammalian CTCF gene, exons 4 through 10 encode the eleven zinc fingers, which allow 
for DNA and protein binding. CTCF binding is methylation sensitive, and it can bind to a 
variety of unmethylated DNA sequences through different combinatorial participation of 
its zinc fingers. CTCF binds to approximately 50,000 sites across the mammalian 
genome81–84.   
CTCF-mediated chromatin looping has been shown to regulate gene expression by 
promoting promoter-enhancer interactions and by maintaining topological boundaries 
between chromatin regions with differing epigenetic signatures85–87. Up to one third of 
CTCF occupied sites are concordant across different cell types (ie constitutive sites)88. 
These sites map to TAD boundaries, suggesting these sites contribute to general genomic 
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structure either TAD maintenance or establishment88. In support of this, the depletion of 
CTCF caused a reduction in within-domain interactions and an increase in inter-domain 
ones76. The non-constitutive binding sites, which account for between 30 to 60% 
(depending on the mammalian species), vary among cell types81,82,84,85. These cell-type 
specific CTCF sites are enriched in enhancer elements and are suggested to be involved in 
cell fate or lineage specifying programs by regulation of gene expression89,90. However, 
only a handful of CTCF occupied sites participate in chromatin looping at a given time in 
a cell, indicating that these chromatin interactions are dynamic91.  
Chromatin looping not only functions to mediate enhancer-promoter interactions, but also 
to physically block a gene from activating regulatory elements; this mechanism of 
regulation is known as insulation. In vertebrates, CTCF is the only protein known to bind 
insulator sequences to elicit this blocking effect92. This function occurs through the 
formation of a loop structure in which the gene promoter can no longer physically interact 
with regulatory elements required for its expression93,94.  
The zinc fingers of CTCF allow for its interaction with a huge diversity of protein binding 
partners and PTM95. As CTCF mediates chromatin loop structures through simultaneous 
interaction with DNA and chromatin-bound proteins at distant sites, its promiscuity in 
protein-binding partners allows for looping specific to cell-types and developmental 
contexts78,79. As with MED, stabilization of the CTCF-based loop structure often also 
involves cohesin. The cooperation of cohesin and CTCF in chromatin loop formation and 
gene regulation has been demonstrated at multiple loci (the HOXA cluster96,97; the 
H19/Igf2 locus98, the IFNG locus99, the beta-globin locus100, and the MHC class II 
locus101), some of which are discussed below. Cohesin and CTCF binding sites largely 
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overlap across the genome, especially near active genes74,102, and multiple studies have 
shown altered gene expression with the depletion of either CTCF or cohesin at specific 
loci94,98–101.  
To summarize, CTCF has both ubiquitous and cell-specific functions in higher order 
chromatin organization, which are mediated by chromatin looping. These functions often 
occur in cooperation with cohesin and regulate gene expression, through physically 
promoting or impeding interaction between distant loci93 
CTCF and imprinted gene regulation 
CTCF has been extensively studied at the imprinted H19/ Igf2 locus98,103–107. In genomic 
imprinting, one of two parental alleles of the gene is repressed though epigenetic 
mechanisms108. Imprinted genes are regulated in clusters by imprinting control regions 
with allele-specific methylation patterns. At the H19/ Igf2 locus, CTCF binding at the 
unmethylated maternal imprinting control region has multiple functions (reviewed in 106). 
First of all, CTCF binding has insulator function, as it prevents the activation of the 
maternal Igf2 allele by a downstream enhancer. This is hypothesized to occur through 
chromatin interactions that place Igf2 in a repressive loop (reviewed in 106). CTCF is also 
implicated in the allelic differences in replication timing at the H19/ Igf2 locus and in 
influencing the chromatin marks in the region109. In the mouse postnatal brain, the 
chromatin remodeling protein ATRX has been shown to be required for CTCF recruitment 
and appropriate expression of the maternal allele of H19105. ATRX is thought to displace 
nucleosomes at the site through its translocase function and expose binding sites for 
CTCF107. CTCF has also been shown to regulate allele-specific chromatin changes at the 
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11p15 imprinted locus, where defects result in Silver-Russell and Beckwith-Wiedemann 
Syndromes (reviewed in 110).  
CTCF and PUMA/ Bbc3 regulation 
The Bbc3 gene encodes a pro-apototic factor called P53-upregulated modulator of 
apoptosis (PUMA). Upon P53 activation, PUMA is expressed (exons 1b, 1a, 2, 3, 4) and 
causes caspase-mediated cell death. Interestingly, when P53 signaling is not active, the 
middle exons of the Bbc3 gene (exons 1a, 2 and 3)  are constitutively expressed as a long 
RNA with no known protein coding function111. The boundaries of the constitutively 
transcribed portion are demarcated by CTCF and cohesin binding, as well as by a sharp 
transition from permissive epigenetic marks (H3K9Ac and H3K4me3) to silencing ones 
(H3K9me3). Upon CTCF knockdown, the cohesin complex was not recruited and 
chromatin boundary signature was reduced, leading to expression of PUMA-coding 
RNA111. In vivo, deletion of Ctcf from the murine limb bud resulted in PUMA expression 
and was accompanied by apoptosis and deformity of limb structures, a feature common in 
Cornelia de Lange Syndrome (CdLS)112. Together this suggests that CTCF and cohesin 
function together to repress PUMA expression in the absence of P53. 
CTCF and protocadherin gene regulation 
The accuracy of neuron connectivity is intimately tied with neuronal diversity at the level 
of the individual cell. In particular, the independent, stochastic mono-allelic autosomal 
expression of clustered protocadherin (Pdch) genes has been implicated.  Whether the 
expression of the variable exon is from the maternal or paternal allele is independently 
regulated for each Pcdh gene, creating a unique combination at the level of the neuron 
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(reviewed in 113). The combinatorial expression of approximately 50 Pcdh genes (α-, β-, 
and γ- clusters), which are members of the cadherin superfamily of homophilic cell-
adhesion molecules, guides neuronal connections by creating a large number of possible 
selective binding units for neuron-neuron interactions and by allowing dendrite self-
avoidance (reviewed in 113). Pcdh promoter choice is determined by promoter/ enhancer 
interactions, through CTCF and RAD21 (member of the cohesin complex) binding. CTCF 
binding at a Pcdh promoter occurs in association with its activation and is dependent on 
the binding-site orientation, which is evidence that this function is mediated through loop 
structures.  
1.2.3 CTCF in development 
In vivo, RNAi-mediated knock-down of Ctcf in oocytes leads to transcriptional 
dysregulation, mitotic defects and apoptosis in 4-cell stage embryos114. In a later study, 
Moore et al.115 generated embryos with loss-of-function Ctcf alleles to distinguish effects 
of maternal Ctcf loss from those of zygotic. These embryos developed up to the blastocyst 
stage but then underwent cell death as maternal stores of Ctcf transcript became depleted. 
Together, these results indicate that CTCF is an essential protein that is necessary for 
embryonic development. Conditional deletion of Ctcf in the developing limb bud results in 
widespread apoptosis, recapitulating the effects of Ctcf loss in the embryo112. However 
when Ctcf is ablated in thymocytes, these cells do not undergo cell death, but instead 
undergo cell cycle arrest due to increased expression of p21 and p27, and are unable to 
differentiate into mature αβ T cells116. These findings show that the tissue-specific function 
of CTCF is diverse, but that roles in cell survival and mitosis are likely shared functions in 
many cell types. 
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CTCF in brain development 
Hirayama et al.117 generated a Ctcf conditional knockout (cKO) mouse in projection 
neurons using the Nex-Cre driver line and floxed Ctcf mice. These cKO mice had postnatal 
growth retardation and displayed abnormal hind-limb clasping, which is a sign of 
neurologic dysfunction. Expression studies revealed that nearly all clustered Pcdh genes 
were down-regulated. The cKO neurons managed to form synapses, but with reduced 
dendritic arborisation and spine density. In addition, these cKO mice had disorganized 
somatosensory cortices. Normally, the pathway from each whisker to the somatosensory 
cortex is organized into “barrelettes”. In the Ctcf cKO mice, staining revealed that the barrel 
segmentation pattern was completely lost, indicative of impaired somatosensory mapping 
during development. 
Watson et al. 118 generated two additional Ctcf cKO mice in embryonic brain tissue. In the 
first, Ctcf is deleted using the Foxg1-Cre driver line at E8.5 in the forebrain and anterior 
retina. This resulted in massive expression of PUMA, and associated apoptosis. The second 
Ctcf cKO model made use of the Nestin-Cre driver line, which mediates deletion of Ctcf at 
approximately E11 in neuroprogenitors across the CNS. Deletion of Ctcf in embryonic 
neuroprogenitors resulted in microcephaly, and perinatal death of resultant pups. The 
apoptosis was rescued by concomitant deletion of Bbc3, the gene encoding PUMA, but 
microcephaly and perinatal lethality were not. These were found to result from aberrant 
proliferation of Ctcf-null radial glia in the VZ/ SVZ and IZ, resulting in premature depletion 
of the neuroprogenitor pool. The effects of Ctcf loss on proliferation in this cell population 
are likely in part due to DNA damage (unpublished data, 119,120).   
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Another group created Ctcf cKO mice using the CamKIIa-Cre driver line, which deletes 
Ctcf in excitatory neurons starting at post-natal day (P) 5, to determine the role of CTCF in 
learning and memory121. These cKO mice had growth similar to controls, but lifespan was 
shortened to about 4 months of age, after massive apoptosis in the hippocampus. The 
dendritic morphology in the hippocampi of 10-week old cKO mice was intact, with the 
exception of the CA1 region, where there was a reduction in spine density with the loss of 
Ctcf. This was associated with deficits in long-term potentiation, the physiological driver 
of learning & memory, as measured from the CA1 in cultured slices. Unsurprisingly, 10 
week old Ctcf cKO had impaired contextual and cued fear memory and impaired spatial 
memory in the MWM paradigm. In addition, these cKO mice had normal sociability but 
had no preference for a novel versus familiar mouse, suggestive of a social memory deficit. 
Next Sams et al performed RNA-sequencing in 10 week old Ctcf cKO and control 
hippocampus and found that Pcdh were down-regulated, similarly to other studies. 
1.3 Neurodevelopmental Disorders 
1.3.1 Overview of Intellectual Disability, Autism Spectrum Disorder, and schizophrenia 
Autism spectrum disorder (ASD) is a persistent neurodevelopmental condition beginning 
in childhood, characterized by i) restricted, repetitive behaviour, and ii) problems with 
social and adaptive functioning, and communication. These behaviours can present as 
motor stereotypies, compulsions, insistence on sameness, reduced eye gaze, literal use of 
words, and poor pragmatic skills. Individuals with ASD also often have Intellectual 
Disability (ID), although either condition can occur without the other. ID typically 
corresponds to an IQ below 70 with deficits in adaptive skills, and affects about 1% of the 
population122. 
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Schizophrenia (SCZ) typically onsets in young adulthood and is a disease that leads to 
altered perception of reality 123. SCZ is characterized by positive and negative symptoms, 
in addition to disordered thoughts and impaired cognition123. Cognitive dysfunction in 
SCZ can manifest as sensory-gating abnormalities, which result in the inability to filter 
irrelevant sensory information (reviewed in 124). Cognitive dysfunction can also manifest 
as a decrease in working memory, measured traditionally using the Wisconsin card 
sorting task125. The dorsal lateral prefrontal cortex (DLPC) is critical for working 
memory, and post-mortem studies have repeatedly found gray matter loss and reductions 
in spine density in this brain region126,127. Positive symptoms include hallucinations and 
delusions, and these are typically responsive to medications which block dopamine 
receptors (reviewed in 128). Negative symptoms pertain to a loss of motivation, impaired 
emotional expressivity, and social dysfunction.  
Evidence suggests that ASD, ID and SCZ have common causal biological factors and 
may exist on a genetic and clinical continuum129,130. Both disorders result from 
perturbations of shared genetic pathways and insults during vulnerable periods of brain 
development from in utero through to early adulthood, converging on mechanisms that 
lead to altered brain connectivity, such as migration and lamination defects, altered cell 
proliferation, and abnormal synapse function and number (reviewed in 131). In the case of 
SCZ, these insults seem to perturb three neurotransmitter systems: the excitatory 
glutamatergic system, the inhibitory GABAergic, and the modulating dopaminergic 
pathway132. There is also evidence for imbalance between excitatory and inhibitory 
systems in ASD133.  
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As there are several single-gene disorders have ASD and ID as core features, most of the 
ASD research has focused on characterizing these genes’ functions. Some of these genes 
include MECP2; the postsynaptic cell adhesion proteins known as Neuroligins (NLGN ; 
reviewed in 134); Neurexins (NRXN) which are interactors of NLGN; Contactin-associated 
protein-like 2 (CNTNAP2; reviewed in 135), which is also a NRXN family member; and 
SH3 and multiple ankyrin repeat domains 3 (SHANK3). Genes associated with SCZ risk 
include Disrupted In Schizophrenia 1 (DISC1)136,137, ERBB4 and its binding partner, NRG1 
(reviewed in 138), among others. There have also been de novo loss of function mutations 
implicated as causal for SCZ, including in SHANK1130. 
In general structural abnormalities on brain imaging for both ASD and SCZ are subtle or 
difficult to reproduce. On MRI, group-wise changes associated with SCZ include smaller 
total brain volume with ventricular enlargement (reviewed in 139). Region-specific 
changes include reduced cortical, hippocampal, and thalamic volumes, and increased 
globus pallidus volume. Others have also found reduced cerebellar volumes in SCZ by 
MRI, and right cerebellar volume was inversely correlated with “neurological soft signs”, 
which include abnormalities in sensory and motor performance140. These are measured by 
changes in speech articulation, finger-to-thumb opposition, finger-to-nose test, tandem 
walking, and right/ left orientation.  Connectivity modeling in SCZ has implicated  the 
cortico- cerebellar–thalamic–cortical circuit141. Dysfunction in this circuitry is thought to 
cause “cognitive dysmetria”, described as impaired processing and response to 
information. 
ASD is very heterogeneous, and is associated with both macrocephaly and 
microcephaly142, and structural MRI in ASD patients found evidence for increased parieto-
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temporal lobe and cerebellar volumes143. Structural MRI of 26 different ASD mouse 
models recapitulated this heterogeneity in brain volume, and when volume-normalized, the 
parieto-temporal lobe, cerebellum, frontal lobe, hypothalamus and striatum were found to 
be structurally abnormal across all models144. Studies in ASD using functional MRI have 
reported patterns consistent with hypo-connectivity dominating across brain regions, and 
some over-connectivity locally145.    
1.3.2 Regulators of chromatin structure cause neurodevelopmental disorders 
Mutations in genes involved in regulating chromatin structure, such as subunits of 
chromatin remodeling complexes, are a major cause of ID, ASD and SCZ (146,147, reviewed 
in 148). In addition, genes encoding proteins involved in chromatin loop formation are also 
implicated in causing these disorders149–152. Whitton and colleagues sought to identify 
shared genetic etiology between SCZ and ID among epigenetic factors, and identified eight 
candidate genes: BCL11B, CHD7, EP300, EPC2, GATAD2A, KDM3B, RERE, and 
SATB2153.  Evidence suggests that the function of chromatin structure regulators converges 
on similar biological processes in the brain, in particular gene regulation.  
Rubinstein-Taybi syndrome: This multisystem disorder is heterogeneous but moderate to 
severe ID is always present (reviewed in 154). This disorder is caused by de novo mutation 
of a single copy of the cAMP response element binding protein (CREB)-binding protein, 
(CREBBP), which encodes transcriptional cofactor called CBP. A milder form of the 
disorder also results from mutation of the paralog of CBP, the E1A-associated protein 300 
gene (EP300), which encodes P300.  Both CBP and P300 are ubiquitous factors that 
function in transcriptional regulation through intrinsic HAT activity as well as by recruiting 
a multitude of transcription factors through protein-binding domains. Enhancers are 
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typically enriched with H3K4me1 or H3K27ac and CBP or P300155,156, but only a subset 
are actively regulating transcription at a given time157. Neuronal activity has been shown 
to increase CBP binding to H3K4me1-enriched sites in cultured mouse cortical neurons158. 
Further experiments159 revealed that acetylation of H3K27 increased at a subset of these 
sites and many of these neuronal activity-regulated enhancers became bound by the early-
response factor FOS. Although these tests were performed in vitro¸ there was 65% overlap 
of these sites with DNaseI hypersensitive sites in murine adult cortex, suggesting these 
regions are functional enhancers in vivo.  
Rett Syndrome: Mutations in MECP2 gene cause a well-studied condition in females 
known as Rett syndrome, a neurodevelopmental disorder that presents at around 6 to 18 
months of age and is characterized by ID, features of ASD, and an increased risk of seizure 
disorder160. MECP2, is a ubiquitous nuclear protein that binds to methylated cytosine 
residues through its methyl binding domain. Emerging evidence suggests MECP2 affects 
transcription by influencing global chromatin organization, as it has been shown to coat 
DNA like a histone161, and even compete with histone H1 for binding sites162. In addition, 
MECP2 functions in heterochromatin condensation163. In the brain, MECP2 recruits 
repressive complexes (HDAC1, HDAC2 and Sin3A) to methylated loci. MECP2 not only 
functions in gene repression, in fact the majority of genes bound by MECP2 in wildtype 
brain showed decreased expression in Mecp2-deficient tissues164. MECP2, like CBP, 
interacts with CREB1 at active promoters. Some of the targets MECP2 activates include 
the brain-derived neurotrophic factor (Bdnf)164, Sst164 and Dlx5165. 
Alpha-thalassemia, mental retardation X-liked (ATR-X) syndrome: This rare disorder 
affects males and is characterized by moderate to severe ID, skeletal and urogenital defects, 
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seizures, and mild alpha-thalassemia166. ATR-X syndrome is caused by hypomorphic 
mutations in the X-linked ATP-dependent chromatin remodeling protein (ATRX), 
typically in either the ADD domain at the N-terminus or SWI/ SNF translocase domain at 
the C-terminus167. The ADD domain allows ATRX to selectively bind the combinatorial 
readout of H3K9me3 and H3K4me0168,169. ATRX is enriched at repetitive, heterochromatic 
GC-rich sequences, and is targeted there by histone marks and through protein-protein 
interactions (reviewed in 170). The translocase domain is theorized to allow for ATP-
dependent chromatin remodelling171, which has been shown to regulate transcription 
through making specific chromatin regions available for deposition of histone variant 
H3.3172. Deposition of H3.3 may be important for transcription and replication machinery 
to pass through GC-rich domains173. Deletion of Atrx from forebrain results in widespread 
P53-dependent apoptosis174, which is likely secondary to replication damage in the 
neuroprogenitors175. 
In addition, ATRX has been shown to be recruited by MECP2 to pericentromeric 
heterochromatin in neurons176, suggesting ATRX may be required as a downstream 
effector of MECP2. The H19 gene is genetically imprinted, which means in some tissues 
it is expressed preferentially from one parental allele (in this case the maternal), and carries 
parent of origin-specific DNA methylation patterns which are stably inherited by daughter 
cells (reviewed in 108). MECP2 was shown to recruit ATRX to the maternal H19 imprinting 
control region in the neonatal mouse brain105,107. Without ATRX or MECP2, repression of 
a network of imprinted alleles is lost in the brain, and may contribute to the overlap of ID 
in the two human disorders105.    
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Cornelia de Lange Syndrome (CdLs): This is a multi-system disorder that causes ID, short 
stature and limb defects, but milder cases can have features of ASD177. CdLS is caused by 
mutations in members and regulators of the Cohesin complex (NIPBL, SMC1A, SMC3, 
RAD21, and HDAC8) (reviewed in 178,179). The cohesin complex is an important 
transcriptional regulator through its role in chromatin loop stabilization, and it is this role 
that has been implicated in the symptomology of CdLS180,181.  Transcriptional profiling in 
embryonic brain tissue from Nipbl mutant mice showed altered expression of the clustered 
Pcdh-β genes181, involved in synapse formation and dendrite avoidance (reviewed in 113). 
The cohesin complex also interacts with MECP2 and ATRX at imprinted loci105. 
Mutations in MED cause ID: Mutations in the X-linked MED12 gene causes at least three 
different conditions associated with moderate to severe ID, and varying other clinical 
features such as heart defects, hypotonia and macrocephaly. Mutations in the MED13L 
gene also cause a similar disorder. These genes encode subunits of MED, and as with 
cohesin, MED is an important regulator of gene expression through its role in loop 
stabilization between promoters and enhancers152.     
1.3.3 CTCF causes autosomal dominant ID and ASD    
Gregor et al149 identified a de novo frameshift mutation in CTCF by performing trio 
exome sequencing for a 9 year-old Caucasian boy with ID (IQ 64), congenital cardiac 
defects, microcephaly, short stature and delayed walking. After identifying this mutation 
in a novel ID gene, they proceeded with unidirectional sequencing of all coding exons 
and exon-intron boundaries of CTCF in a cohort of 399 children with ID. Two other boys 
with mutations in CTCF were identified, one with a de novo frameshift mutation and the 
other with a de novo missense mutation. The boy with the frameshift had mild ID (IQ 79– 
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86), global developmental delay, muscular hypotonia, microcephaly, cryptorchidism and 
recurrent infections. The second proband, carrying the missense mutation, was a boy with 
severe ID (no IQ score available), global developmental delay, microcephaly, autistic 
behaviour, feeding difficulties and cryptorchidism.    
Whole transcriptome sequencing was performed on lymphocytes from these three 
individuals and 8 healthy controls. The expression patterns were more similar between 
those individuals with frameshift mutations, than the missense, but the three individuals 
still had significant overlap of up- and downregulated genes, indicating common 
pathogenic transcriptional changes. The authors evaluated a set of 698 downregulated 
genes for Gene Ontology (GO) terms, finding enrichment in biological processes of 
inflammatory response, signal transduction, and chemotaxis. Upregulated genes (set of 
118) were enriched for GO terms implicated in protein translation and processing. 
To date there have been three studies describing patients with ID and disruption or 
mutation of the CTCF gene, a syndrome described as Autosomal Dominant Mental 
Retardation 21 (MRD21)149,182,183. Along with the three individuals from their own 
database, Gregor et al. identified a fourth individual with ID and a 280 kb deletion 
spanning eight genes including CTCF149.  Another group performed whole-exome 
sequencing of 2508 children with ASD to identify de novo mutations183. Of note, there 
was significantly more males in the screened affected population than females, as 
commonly is the case with ASD, by a ratio of 1 female to every 7 males. There were two 
ASD probands identified with mutations in CTCF; one with a frameshift mutation (a 
female), and the other with a missense mutation (a male). Both of these individuals had 
reduced non-verbal IQ, with scores of 61 and 51, respectively.  
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The third study was a case report that described a female with a de novo frameshift 
mutation in the CTCF gene, identified by whole exome sequencing182. She was extremely 
small for gestational age, and at birth weighed below the 3rd percentile, while head 
circumference was under the 10th percentile, consistent with previous findings that CTCF 
haploinsufficiency leads to short stature and microcephaly. Along with global 
developmental delay, she suffered repeated respiratory infections and had minor heart 
abnormalities (small atrial septal defect), all of which were reported previously with 
CTCF mutation.    
1.3.4 CTCF is associated with SCZ 
Juraeva and colleagues150 sought to investigate the joint effects of multiple functionally 
related pathways (pathway-based analysis of GWAS),  which provides more power to 
genetic association studies.  They applied a hierarchical approach, using the Global Test, 
to identify altered gene pathways184. Next, they used FORGE185 to identify important risk 
genes within the Global Test- selected pathways. They increased the robustness of their 
study by using two separate datasets, one containing 5040 individuals with SCZ, and the 
other consisting of 5082.  
The Global Test yielded 27 significantly associated pathways, of which 14 pathways 
were significantly associated with SCZ in the replication dataset. Using FORGE to 
perform gene-based analysis on these results identified 100 genes, of which 8 genes 
overlapped with 4 or more of the 14 replicated significant pathways (FOXP2, BCL11A, 
PCDH7, RPL36P13, CACNB2, CTCF, MECOM, and RIMS1). The 100 genes were 
tested for association, which yielded 18 genes significantly associated with SCZ. Among 
these were multiple known SCZ susceptibility genes. CTCF and CACNB2 were among 
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this set of genes as well, and were tested separately in the replication sample, where 
CTCF again was strongly associated with SCZ, and CACNB2 showed a trend toward 
association.             
1.3.5 Evidence for cortical interneurons in neurodevelopmental disorders 
Most of the evidence for cortical interneuron dysfunction in ASD comes from studying the 
genes associated with monogenic syndromic ASD (MECP2, and members of the NLGN, 
NRXN and SHANK molecular families). Deletion of Mecp2 from forebrain GABAergic 
interneurons is sufficient for mice to recapitulate ASD phenotypes (repetitive behaviours, 
altered sociability, cognitive deficits), suggesting these behaviours are mediated by 
interneuron dysfunction186. In addition, when NRXN family member Cntnap2 is deleted in 
mice, this results in a reduced number of PV interneurons187.  Post-mortem studies in ASD 
are limited, but some samples from ASD patients have shown reduced GAD65/67 in 
cortex188. One study also implicates altered interneuron subtype ratios in the cortex of ASD 
patients133.  
In SCZ, reductions in cortical interneurons as measured by Gad1 mRNA have been found 
across several cortical regions189,190, reviewed in 191. In addition, there are reports of 
increased GABA receptor (A) α2 subunit192,193 and decreases in GABA receptor (A) sub-
units α1 and α5189,193 in SCZ, suggesting that GABAergic signaling in general is altered.  
It has been suggested that reductions in GABAergic cell numbers in the cortex of SCZ 
may occur due to defects in migration from the ganglionic eminence. In support of this, 
an increased number of interstitial neurons in the white matter (IWMN) have been found 
in post-mortem SCZ samples194–199. These IWMN could represent cortical interneurons 
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that have lost their way during tangential migration200. Others have suggested that 
although cortical interneuron number may be affected in some patients with SCZ, 
interneuron dysfunction is more relevant to the spectrum of the disease (reviewed in 201).     
As mentioned in a prior section, cortical interneurons influence synchronicity of activity to 
generate oscillation. PV-expressing interneurons give rise to gamma oscillatory activity, 
described in the frequency range of 30-80 Hz202. Gamma oscillatory patterns are 
reproducibly abnormal in the brains of SCZ patients, suggesting a role for PV-expressing 
interneuron dysfunction203–205. In support of this, reduced staining for PV has been found 
in SCZ206–209. Others have found reduced GAD67 staining in specific subclasses of 
interneurons of the DPFC in SCZ, suggesting a decreased potential to secrete GABA194,210. 
It has been suggested that these deficits in PV interneurons can stem from dysfunction of 
their NMDARs. Neurons, including interneurons, can respond to excitatory glutamate 
through NMDAR. Taking antagonists of NMDAR (eg. PCP) produces a phenotype similar 
to SCZ and alters gamma oscillations (reviewed in 211). Culturing neurons with NMDAR 
antagonists results in reduced Gad1 and Pv mRNA212, and animal studies also support that 
down-regulation by blocking NMDAR in PV interneurons is sufficient to generate SCZ 
phenotypes, such as altered gamma oscillations213.   
Studies of SCZ risk-genes (DISC1, ERBB4, and NRG1), provide further evidence for PV 
interneuron dysfunction in SCZ. Outside of guiding interneuron tangential migration, 
ERBB4 has important roles in the function of mature interneurons214. Deletion of ErbB4 
from PV interneurons in mice resulted in reduced synapsing between chandelier and 
excitatory neurons214,215. Transgenic mice that express mutant forms of Disc1 also have PV 
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interneuron abnormalities, including reduced PV expression216, and reduced or mal-
positioned PV interneurons217,218. 
Although the evidence for PV interneuron dysfunction in SCZ is strong, the loss of SST 
staining is also robustly reported189,209,219, suggesting that there may be alterations 
occurring at the level of MGE development. In support of this, both LHX6220 and NKX2.1221 
have been implicated in schizophrenia. LHX6 mRNA levels were lower in schizophrenia 
cortex and correlated with lower GAD67 levels as well.   
1.4 Mouse models of neurodevelopmental disorders 
1.4.1 Behavioural phenotyping of SCZ and ID/ASD mouse models 
Animal models are evaluated based on face validity (reproduce phenotypes of human 
syndrome), construct validity (demonstrate the same underlying biological dysfunction as 
in human condition), and predictive validity (have analogous response to treatment as in 
patients). Common mouse models for ASD, ID and SCZ and their behavioural deficits are 
presented in Table 1.  
 
 
Table 1: Summary of behaviours of common ASD, ID and SCZ rodent models 
Rodent Model/ 
Gene 
Disorder Modeled Behaviour References 
Post-weaning 
social isolation 
(rats) 
Attention Deficit/ 
Hyperactivity 
Disorder (ADHD) 
SCZ 
Hyperactivity, enhanced 
responses to novelty, impaired 
PPI, cognitive inflexibility, 
impaired fear learning, and 
increased aggression   
Reviewed in 
1 
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Maternal 
immune 
activation 
(rats) 
SCZ  
ASD 
Abnormal communication, 
decreased sociability, increased 
repetitive behaviors, impaired 
PPI, impaired working memory, 
cognitive inflexibility, increased 
anxiety, and enhanced reactivity 
to amphetamines  
Reviewed in 
2 
Disc1 mutants 
(mice)  
Haplo-
insufficiency:  
i) exon 8 
Termination, 
(∆25 bp); ii) ∆ex 
2/3; iii) ∆ex1-3 
(Disc1-LI) 
Point mutation: 
i) L100P 
homozygote; ii) 
Q31L 
homozygote 
Transgenic: 
Dominant-
negative (DN) 
DISC1 
expression 
SCZ 
ASD 
Mood Disorder 
 
∆25 bp: Impaired working 
memory 
∆ex 2/3: Increased impulsivity  
Disc1-LI: Normal behaviour 
L100P: Impaired PPI and 
decreased acoustic startle, 
hyperactivity, impaired working 
memory. Normal sociability 
(Note: On other genetic 
background, this mutant was 
indistinguishable from controls).  
Q31L: Decreased sociability and 
social memory, impaired PPI, and 
depressive-like traits 
DN-DISC13: Hyperactivity, 
impaired PPI, and depressive-like 
traits. Normal working memory. 
Sociability not tested  
DN-DISC14: Depressive-like 
traits, impaired working memory, 
and decreased sociability 
DN-DISC15: Hyperactivity. 
Males: Decreased social 
approach, increased aggression. 
Normal spatial learning and 
memory. Females: Impaired 
spatial memory 
Point 
mutations6 
 
Reviewed in 
7 
 
Transgenics: 
3–5 
Erbb4 / Nrg1 
mutants (mice) 
 
SCZ Erbb4-null, Erbb4 cKO (Pv-Cre) 
and Nrg1 hypomorphs8: 
Hyperactivity, and impaired PPI. 
In addition, Errb4-null have 
decreased anxiety. Erbb4 cKO 
(Lhx6-Cre)9: Hyperactivity, 
reduced anxiety, decreased 
sociability, disorganized nests, 
impaired working memory, and 
impaired PPI   
8–10 
 
Neuroligin 
(Nlgn) mutants 
(mice) 
ASD and ID (NLGN 
3, 4) 
SCZ (NLGN 2) 
Nlgn1 KO: Decreased sociability, 
impaired spatial learning and 
memory, and increased repetitive 
behavior. Nlgn2 KO: Normal 
Reviewed in 
11 
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social approach, increased 
anxiety, decreased pain sensitivity 
and poor motor coordination. 
Nlgn3 KO: Decreased sociability, 
altered communication, repetitive 
behaviour, and hyperactivity. 
Nlgn4 KO: Decreased sociability, 
altered communication, and 
repetitive behaviour 
Shank 1, 2, 3 
mutants 
 
ASD 
SCZ 
ID 
ADHD 
Bipolar Disorder 
Shank1-null: Impaired fear 
memory. Altered male-female 
social interactions and 
vocalizations, increased self-
grooming, and increased anxiety. 
Shank2-null: Decreased 
sociability, altered 
communication, repetitive 
jumping, decreased digging, 
impaired spatial learning, 
hyperactivity and increased 
anxiety. Shank3-null: Altered 
social approach/ communication, 
and increased self-grooming 
Reviewed in 
11,12 
Mecp2  
i) ∆ exon ¾ 
(Mecp2tm1.1Bird), 
ii) 308X; iii) Pv-
Cre Mecp2 cKO 
ASD 
ID 
Rett Syndrome 
Female Mecp2tm1.1Bird develop 
uncoordinated gait, reduced 
spontaneous movement, hind-
limb clasping and irregular 
breathing between 3-9 months of 
age. Male Mecp2308X similar, with 
altered social interactions, 
increased anxiety, and 
stereotypies at 6 weeks of age. 
Pv-Cre cKO: Impaired motor, 
impaired acoustic startle, 
impaired cued fear memory, and 
increased social novelty 
preference 
Mecp2tm1.1Bird 
13 
Mecp2308X 14 
Pv-Cre 
Mecp2 cKO15 
Modeling ASD 
As ASD diagnosis is based on behavioural criteria, phenotyping these correlates in mice 
became essential for developing mouse models to study ASD-implicated genes (reviewed 
in 222). There are currently over 70 mouse models of ASD223, and behaviour testing 
focuses on abnormal social behaviour, altered communication, and repetitive / 
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perseverative behaviours. Mice have spontaneous stereotypies such as jumping, backflips 
and self-grooming224. Altered social behaviour typically presents as decreased sociability 
and decreased social memory in the social choice assay222, but the opposite has also been 
observed225. The way mice communicate is not well understood, but some have used 
olfactory cues and olfactory habituation testing in ASD mouse models (reviewed in222). 
Complex ultrasonic vocalizations226, for example in pups separated from the dam and 
nest, have been shown to be abnormal in ASD mouse models227. 
In addition, learning and memory deficits are often observed in ASD mouse models228. 
Mice have a well-developed ability to navigate in space as part of their natural ethology. 
Therefore, spatial memory acquisition, which is dependent on the hippocampus and 
entorhinal cortex (reviewed in 229), is typically used to test learning in mice.  
Modeling SCZ 
In SCZ, creating mice with face validity has been more challenging230,231. Here the 
behaviours usually model i) the negative symptoms by abnormal social behaviour, ii) 
impaired cognition by decreased working memory and cognitive inflexibility, and iii) 
positive symptoms by hyperactivity at baseline or in response to psychotomimetic drugs.   
SCZ mouse models tend to show decreased sociability231. Decreased aggression, 
representing social withdrawal, as well as increased aggression, have also been observed 
in SCZ mouse models232. In mice, behavioural inflexibility can be tested with reversal 
learning tasks (reviewed in 233) and is relevant to both ASD and SCZ. Working memory 
can also be tested in rodents using maze paradigms which require short term-memory and 
manipulation of the stored information to perform (reviewed in 234). 
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Hyperactivity has been observed in many SCZ animal models at baseline, or in response 
to novelty, while others have detected increased locomotor activity in response to 
NMDAR antagonists, dopamimetic drugs, amphetamine, or cocaine compared to control 
animals (reviewed in 231). In addition, sensory-gating abnormalities have been observed 
in SCZ patients, and are readily modeled in animals232. In SCZ mouse models, there is 
often a reduction in PPI due to abnormal sensory filtering of the prepulse stimulus. 
1.5 Rationale 
Genes encoding regulators of chromatin higher order structure are being increasingly 
implicated in ASD, ID and SCZ (see section 3.2), however our understanding of how 
they influence brain development and behaviour remains poorly understood. CTCF 
functions in the regulation of gene expression through influencing higher order chromatin 
structure. It has an irrefutably important role in brain development, as its mutation results 
in intellectual disability and ASD149,183. In addition, CTCF has been associated with SCZ 
in two patient samples150. Despite this, there have only been a handful of studies 
exploring the role of CTCF in the brain, in particular during development.  
1.6 Hypothesis 
The over-arching hypothesis of this thesis is that CTCF is required for the development 
of normal cell type composition, brain structure and behaviour by regulating gene 
expression at the embryonic stage. In addition, because of the syndrome associated with 
single copy mutation of CTCF, I hypothesize that haplo-insufficiency of Ctcf in the 
mouse brain will resemble other rodent models of ASD, ID and SCZ in behaviour and 
brain structure.      
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1.7 Objectives 
(1) Identify genes important during brain development that are affected by loss of Ctcf.  
This will involve the generation of appropriate mouse models to explore the outcome of 
Ctcf loss and examine differential transcriptional profiles in the developing forebrain. 
Based on this transcriptional screen, we will focus on specific genes implicated in key 
events during brain development and that potentially could be linked to ID, ASD or SCZ 
etiology. Cellular effects will be examined using in vivo models and causality of 
phenotypes verified by rescue experiments. 
(2) Determine the effect of Ctcf haplo-insufficiency on brain morphology and behaviour.  
 To achieve this, I will generate mice with conditional deletion of a single copy of Ctcf in 
the embryonic central nervous system.  If the mutant mice survive to adulthood, they will 
be subjected to a battery of behavioural tasks relevant to ASD, ID, and SCZ and brain 
morphological changes will be evaluated by MRI. 
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2.1 Abstract 
CTCF is a chromatin organizer linked to schizophrenia, intellectual disability and autism 
spectrum disorder. Here we show that loss of Ctcf disrupts the dichotomy between Lhx6 
and Lhx8 transcriptional cascades in the MGE, which is critical for fate determination of 
cortical PV and SST expressing interneurons.  Conditional Ctcf ablation MGE led to a 
marked reduction of these cell types in the postnatal neocortex and to cortical interneuron 
lamination defects. Re-expression of Lhx6 in Ctcf-null MGE cells in transplantation 
experiments rescued cortical SST interneuron number and interneuron lamination defects, 
indicating that these particular outcomes of Ctcf deletion are due to decreased expression 
of Lhx6 in the MGE. Conversely, we detected a surplus of MGE cells expressing Lhx8 
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that gain markers of GABAergic projection neurons of the basal forebrain, indicative of a 
fate switch. Collectively, these findings suggest that CTCF-mediated chromatin 
organization in embryonic progenitor cells of the MGE is essential for the fate and 
differentiation of cortical interneurons and the establishment of functional inhibitory 
networks. 
2.2 Introduction 
Interneurons that produce γ-aminobutyric acid (GABA) provide the rhythmic inhibitory 
activity that synchronizes pyramidal cell firing in mature neuronal circuits of the cortex 
(reviewed in 1). Not surprisingly, perturbation of the cortical GABAergic system has been 
observed in several neurodevelopmental disorders, including Down Syndrome2, 3, Fragile 
X syndrome4, 5, and autism spectrum disorder (ASD)6, 7,  and pharmacological 
modulation of GABA receptors has been therapeutic in some contexts8, 9. Recently, the 
transplantation of immature interneurons into the postnatal cortex has been explored as an 
alternative to pharmacological therapy in mouse models of epilepsy10, 11, 12.  The laminar 
position and marker expression of cortical interneurons depend more on intrinsic factors 
than extrinsic, and transplanted cortical GABAergic interneurons have the potential to 
integrate into existing circuits. Understanding the developmental steps and regulatory 
events governing cortical interneuron development is thus essential to generate 
interneurons for successful therapeutic transplants.  
In mice, the majority of cortical interneurons are mainly produced in the ventral 
telencephalon in transient structures called the medial ganglionic eminence (MGE) and 
the caudal ganglionic eminence (CGE). MGE- and CGE-derived interneurons migrate 
tangentially into the developing cortical marginal and intermediate zones before radially 
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invading the cortical plate and forming connections with the cortical pyramidal neurons13.  
Transcriptional cascades in the MGE result in a peak of neurogenesis between embryonic 
(E) days 12-14 that generates the future Somatostatin (SST) and Parvalbumin (PV)-
expressing GABAergic interneuron subtypes14,15. MGE secondary progenitors (in the 
subventricular zone) and a subset of post-mitotic neurons express both LHX6 and LHX8, 
two LIM homeobox factors with partially overlapping function16,17. The cells destined to 
become cortical interneurons express only LHX6, while the neurons that express LHX8 
(some in combination with LHX6) are fated to become cholinergic interneurons or 
pallidal GABAergic projection neurons16,18. Lhx6-null interneurons resemble CGE-
derived neurogliaform interneurons with regard to marker expression, laminar position 
and electrophysiology19, indicating that LHX6 can specify the fate of MGE-derived 
interneurons. 
CTCF is a ubiquitously expressed protein that orchestrates loop formation in chromatin 
by binding to a consensus sequence and simultaneously dimerizing or partnering with 
other chromatin-associated proteins like the cohesin complex (reviewed in20). These 
loops can bring distant genomic elements into close proximity, such as promoters and 
enhancers, or act as a barrier, such as when CTCF functions as an insulator protein.  In 
parallel, emerging evidence suggests that CTCF is required for normal development and 
functioning of the central nervous system. De novo mutations in one copy of the human 
CTCF gene were recently identified in five patients with microcephaly, intellectual 
disability (ID), and short stature21,22.  Two individuals with ID screened as part of a 
cohort selected for ASD were also identified as having mutations in one allele of CTCF23. 
Polymorphisms in and around the CTCF gene have also been associated with 
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schizophrenia in two different patient-control cohorts24. Moreover, CTCF has been 
shown to regulate the expression of the protocadherin membrane adhesion proteins for 
which the combinatorial expression in neurons is thought to underlie the specificity of 
neuronal connectivity25. The analysis of dorsal projection neurons in Ctcf-deficient mice 
revealed defects in dendritic arborisation and reduced spine density25. Viral-mediated 
knockdown of Ctcf in hippocampal cells also results in reduced spine density and leads to 
impaired learning26.    
In this study we present our findings from Ctcf gene inactivation in the developing mouse 
ventral telencephalon. We show that CTCF expression is required for the normal 
development and fate specification of MGE-derived cortical GABAergic interneurons. 
Ctcf deletion results in reduced expression of Lhx6, and an up-regulation of Lhx8, 
resulting in aberrant fate specification and reduced number of cortical PV+ and SST+ 
interneuron subtypes. Re-introduction of Lhx6 in CTCF-null MGE progenitors is 
sufficient to re-establish the normal number of SST-positive interneurons and lamination 
pattern in transplantation experiments. These findings suggest that disturbing chromatin 
organization during embryonic ventral telencephalon development can affect postnatal 
cortical inhibitory activity, perhaps contributing to cognitive abnormalities. 
2.3 Results 
2.3.1 RNA-seq of CTCF-null telencephalon identifies clustered protocadherins and genes involved 
in GABAergic neuron differentiation 
We previously reported dorsal telencephalon defects upon conditional inactivation of Ctcf 
in the embryonic brain using the NestinCre driver line of mice27, which deleted Ctcf in 
early neural progenitors (radial glia). Analysis of the dorsal forebrain of E16.5 CtcfNes-Cre 
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revealed extensive TP53 and PUMA-dependent cell death as well as premature 
differentiation of neural precursor cells, leading to depletion of the progenitor pool27.  
Taking advantage of the short period of time preceding apoptosis induction, we 
proceeded to identify differences in the E14 telencephalon transcriptomes of CtcfNes-Cre 
and littermate control embryos. Using a criterion of i) a minimum expression of 2% of 
the average reads, and ii) a minimum average fold-change of 1.5, we generated a list of 
genes (n= 2024) with altered expression in the CtcfNes-Cre E14 forebrain (Fig. 1A). Of this 
list, about half (n=1050) exhibited decreased expression in the CtcfNes-Cre E14 
telencephalon. A large number of the down-regulated genes belonged to the clustered 
Ca2+binding protocadherin (Pcdh) genes, with a more pronounced effect on Pcdh- genes 
(Fig. 1A,B). We confirmed the effects of Ctcf inactivation on the Pcdh genes by 
quantitative RT-PCR (Fig. S1). These results expand on previous reports by 
demonstrating embryonic regulation of the Pcdh cluster genes by CTCF prior to neuronal 
network establishment.  
The list of down-regulated genes was analyzed for GO term enrichment using PANTHER 
version 11.1 (Pantherdb.org). The significantly enriched GO Biological Processes with 
>2.0 fold enrichment included several terms related to synaptic transmission, which 
might be expected in light of recent studies implicating CTCF in learning and memory26. 
Of note was the unexpected enrichment for genes involved in GABAergic neuron 
differentiation, suggesting a potential novel role of CTCF in the embryonic production of 
inhibitory interneurons. 
 
71 
 
 
Figure 3 Transcriptional profiling of Ctcf-null E14 telencephalon. 
Figure 1: Transcriptional profiling of Ctcf-null E14 telencephalon. (A) Log2 of 
normalized read counts of control and CtcfNes-Cre E14 telencephalon RNA sequencing. 
Pcdh cluster genes are highlighted in colour.  Inset provides a view of low-expressing 
genes using a linear scale. (B) Heatmaps of Pcdh gene expression across the a, b and g 
clusters. (C) List of top ten Gene Ontology terms for biological processes showing 
enrichment in the list of genes downregulated in CtcfNes-Cre E14 telencephalon. The list 
was generated using the PANTHER over-representation test. P-values with a Bonferroni 
correction are shown on the right for each category. 
2.3.2 Ctcf regulates the expression of Lhx6 and Lhx8 in the MGE 
The list of down-regulated genes in the CtcfNes-Cre E14 telencephalon included Lhx6, 
which encodes a master transcription factor critical for the development of cortical 
GABAergic interneurons28. LHX6 is required for the production of PV+ and SST+ 
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interneuron subtypes derived from the MGE that eventually populate multiple areas of 
the forebrain, including the striatum and cortex. RT-qPCR confirmed a ~2.5-fold 
decrease in Lhx6 transcript levels (P=0.028). Similarly, the expression of Sst, a known 
downstream target of LHX6, exhibited a ~10-fold decrease in expression (P=0.0001) 
(Fig. 2A). In situ hybridization (ISH) of E13.5 embryonic sections confirmed decreased 
Lhx6 mRNA in the CtcfNes-Cre MGE (Fig. 2B) and we observed that in a subset of 
embryos, reduction in Lhx6 expression was restricted to the caudal MGE (data not 
shown). ISH of Sst transcripts identified fewer Sst+ cells migrating tangentially from the 
MGE towards the cortex in the CtcfNes-Cre compared to control embryos (Fig. 2C). Given 
that CTCF protein expression is no longer detectable in the MGE of the CtcfNes-Cre 
embryos by E12.527 (Fig. S2A), we examined Lhx6 expression at this time point by ISH, 
and observed only a subtle decrease in the CtcfNes-Cre MGE compared to control (Fig. 
S2B). Together, these data suggest that Lhx6 expression is affected in the CtcfNes-Cre MGE 
mostly after E12.5, and this reduction either begins with, or is most pronounced in cells 
of the posterior MGE. 
We considered the possibility that the reduction in Lhx6 transcripts reflected a loss of 
cells due to apoptosis of Ctcf-null neuroprogenitor cells. We previously reported that 
apoptosis in the CtcfNes-Cre embryonic brain can be prevented by concomitant deletion of 
the Bbc3 gene, which encodes the TP53 apoptotic effector PUMA27. We thus repeated 
ISH for Lhx6 and Sst in CtcfNes-Cre embryos in a PUMA-null background. We find that 
preventing apoptosis of cells in the CtcfNes-Cre telencephalon via removal of PUMA fails 
to rescue the level of Lhx6 or Sst (Fig. 2D,E). To determine whether the reduction of 
Lhx6 and Sst transcript levels in Ctcf mutant embryos results from decreased cell 
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proliferation, we performed acute BrdU incorporation assays to calculate the percentage 
of proliferating cells in the ventricular zone of the MGE at E12.5, during the peak of 
neurogenesis. There was no significant difference in the proliferative capacity of the Ctcf-
null MGE compared to control (Fig. S2C). Together these results indicate that the 
reduction of Lhx6 and Sst transcripts is not caused by altered survival or proliferative 
capacity of Ctcf-deficient MGE cells. 
Beginning at E9.75, MGE cells are specified in the ventricular zone by NKX2.1, a 
transcription factor necessary for the expression of Lhx6 and Lhx8.  Through unknown 
mechanisms, a subset of the cells that co-express these genes become either LHX6 or 
LHX8 positive16. LHX8 promotes a genetic program specifying telencephalic cholinergic 
interneurons that remain in the basal ganglia as striatal interneurons, or projection 
neurons in the septum and pallidum and Lhx8-deficient mice have a reduced number of 
these cell types29. We therefore also examined the effect of CTCF loss on Lhx8 
expression by ISH and RT-qPCR of RNA isolated from the MGE. In contrast to Lhx6, 
the expression of Lhx8 was significantly increased compared to control (P=0.0058), 
suggesting that a greater number of MGE cells retain Lhx8 at the expense of cells 
retaining Lhx6 expression (Fig. 2F,G,I). Increased expression of Gbx2, a downstream 
target of LHX829, indeed supports a scenario where Ctcf-null MGE cells might 
implement different fate pathways due to the reduced Lhx6 expression and the increased 
Lhx8 expression (Fig. 2F,H,J). 
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Figure 4: The Ctcf-null embryonic MGE exhibits altered expression of genes 
implicated in fate specification. 
Figure 2: The Ctcf-null embryonic MGE exhibits altered expression of genes 
implicated in fate specification. (A,D) RT-qPCR of E14 telencephalon (or MGE for 
Lhx8) isolated from control (grey) or CtcfNes-Cre (blue) embryos (n= 3 pairs). Data was 
normalized to β-actin expression. Asterisks demark P <0.05, Student’s t-test. Error bars 
represent SEM. (B-J) ISH of the indicated transcripts on E13.5 coronal brain sections of 
control and CtcfNes-Cre embryos (B, C, E, F) or PUMA-/- and CtcfNes-Cre ; PUMA-/- 
embryos (G-J). Scale bars represent 100 µm. Tissue edges are outlined for ease of 
visualization. 
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2.3.3 CTCF acts in parallel to, or downstream of NKX2.1 to regulate Lhx6 and Lhx8 expression 
Since NKX2.1 induces the expression of Lhx6 and Lhx8, we wondered whether CTCF 
acts upstream or in parallel with this transcription factor in the embryonic MGE. Western 
blot analysis demonstrates that NKX2.1 protein level is not altered in E13.5 CtcfNes-Cre 
compared to littermate-control forebrain tissue (Fig. 3A). We also stained coronal slices 
of E13.5 CtcfNes-Cre and littermate-control embryos with an anti-NKX2.1 antibody which 
showed no obvious change in NKX2.1 levels or localization (Fig. 3B). We next tested 
whether CTCF interacts with NKX2.1 to regulate Lhx6 and Lhx8 by co-
immunoprecipitation of CTCF and NKX2.1 in pooled MGE tissue dissected from 
wildtype E13.5 embryos, but found no evidence for an interaction between these two 
proteins (Fig. 3C). In addition, we compared the chromatin occupancy of these two 
factors by ChIP-seq analysis. ChIP-seq for CTCF was performed on pooled wildtype 
E13.5 MGE tissue and the data obtained was compared to previously published NKX2.1 
ChIP-seq data30. We find that only a small percentage of CTCF peaks (6.5%) overlap 
with NKX2.1 binding sites (P<0.01, Fig. 3D). Regulatory elements previously identified 
in the promoter and in the first intron of Lhx631,32 do not exhibit CTCF binding (Fig. 3E). 
We also examined CTCF binding to several enhancers that have activity in the MGE32: 
enhancer 422 (chr2:71,373,435–71,374,614 [mm9]), DlxI12b (chr2:71,374,047–
71,374,552 [mm9]), the murine sequence corresponding to enhancer 692 near the human 
SOX6 gene (chr7:122,275,029-122,275,957 [mm9]), the murine sequence corresponding 
to the human enhancer 1056 (chr18:81,349,730-81,351,184 [mm9]), and the murine 
sequence corresponding to the human enhancer 1538 (chr2:71,373,514-71,374,608 
[mm9]). No peaks corresponding to CTCF binding are found at any of these sites (data 
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not shown). On the other hand, we observed CTCF-binding sites that flank a large 
genomic region surrounding Lhx6, suggesting that CTCF may promote long-range loop 
formation perhaps required for proper regulation of Lhx6 by NKX2.1. We also examined 
the pattern of CTCF binding at the Lhx8 locus, and identified a peak in intron 6 and 
another ~30kb upstream of the gene (Fig.3E). This pattern of CTCF binding has been 
observed at other loci that exhibit negative transcriptional regulation by CTCF, including 
the Bbc3/PUMA gene33.  Altogether, these data suggest that CTCF could act either in 
parallel or downstream of NKX2.1 to control Lhx6 and Lhx8 expression. 
2.3.4 CTCF regulates MGE development cell-autonomously 
While useful for the investigation of early forebrain development, the CtcfNes-Cre mice 
present some drawbacks: extensive cell death ensues beyond E15.5 in the telencephalon 
and the mice die in the perinatal period, preventing any postnatal analysis of cortical 
GABAergic interneurons. To circumvent these difficulties, we deleted Ctcf using the 
Nkx2.1Cre driver line, hereon referred to as CtcfNkx-Cre mice, which is expressed in 
progenitors of the MGE and the preoptic area (POA). In this model, Ctcf deletion occurs 
in the MGE before E12.5. CTCF absence from the MGE was confirmed by 
immunofluorescence staining of brain sections at E13.5. Loss of CTCF expression is seen 
in most of the MGE, except for a small dorso-medial region in some embryos, as reported 
previously by others19 (Fig. 4A). Importantly, Ctcf deletion in the E13.5 MGE 
recapitulates differences in Lhx6, Sst, and Lhx8 transcripts detected in CtcfNes-Cre embryos, 
establishing that these transcriptional effects are cell autonomous (Fig. 4B-D). CtcfNkx-Cre 
mice are smaller than controls and exhibit failure to thrive postnatally (Fig. 4E-G). While 
this could be caused by loss of CTCF in the MGE, NKX2.1-driven Cre expression can 
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sometimes occur in the lung and the thyroid34, and reduced survival of CtcfNkx-Cre could be 
caused by Cre-mediated deletion of Ctcf in these tissues. In support of this, we found that 
circulating thyroxine (T4) levels were reduced in CtcfNkx-Cre mice aged P20-22 (Fig. S3). 
 
Figure 5: CTCF functions in parallel or downstream of Nkx2.1 to regulate Lhx6 and 
Lhx8 
Figure 3: CTCF functions in parallel or downstream of Nkx2.1 to regulate Lhx6 and 
Lhx8. (A) Western blot of NKX2.1 in four control (C) and CtcfNes-Cre (KO) E13.5 
telencephalons. β-actin was used as a loading control for normalization. Quantification is 
shown graphically on the right. Error bars represent SEM.  P=0.968, Student’s t-test.(B) 
NKX2.1 immuno-fluorescence staining (red) in E13.5 coronal sections. Nuclei were 
counterstained with DAPI (blue). Scale bar represents 100 µm. (C) Co-IP of CTCF and 
NKX2.1 using pooled wildtype MGE tissue. Asterisks indicate non-specific IgG band. 
(D) Venn diagram showing the overlap of CTCF and NKX2.1 ChIP-seq peaks in the 
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MGE (p<0.01) (E) Diagram depicting UCSC genome browser views of the Lhx6 and 
Lhx8 loci (boxed), ChIP-seq peaks for NKX2.1, CTCF and input as well as the RNA-seq 
tracks of control and CtcfNes-Cre E14 telencephalon. Relevant CTCF binding sites are 
indicated by arrows. 
 
Figure 6: MGE-specific inactivation of Ctcf replicates gene expression changes and 
extends postnatal survival. 
Figure 4: MGE-specific inactivation of Ctcf replicates gene expression changes and 
extends postnatal survival. (A) CTCF immunofluorescence staining (green) of E13.5 
CtcfNkx-Cre coronal brain sections. Nuclei are counterstained with DAPI. Higher 
magnification view of the MGE is shown on the right. Scalebar, 100 µm. (B) RT-qPCR 
of Lhx6, Sst and Lhx8 in E14 telencephalon normalized to β-actin (n=3). Error bars 
represent SEM and asterisks denote P< 0.05 by Student’s t-test. (C-D) ISH of Lhx6 and 
Sst in E13.5 coronal sections. Scalebar, 100 µm. Tissue is outlined for ease of 
visualization. (E) Representative image of a 12 day-old CtcfNkx-Cre male mouse and 
littermate control. (F) Plot of weights of CtcfNkx-Cre (n=4) and littermate controls (n=12) 
over time. Error bars represent SEM. (G) Survival curve of CtcfNkx-Cre mice (males=4; 
females=5). Five animals were sacrificed due to severe distress or imminent death. 
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2.3.5 MGE-specific deletion of Ctcf leads to a reduction of cortical interneurons expressing Pv and 
Sst 
Tangential migration of MGE interneurons into the developing dorsal pallium is 
mediated by several molecular signals downstream of LHX6, including the interaction of 
chemoreceptors CXCR4 and CXCR7, present on the interneuron cell surface, with 
stromal cell-derived factor 1 (SDF1), which is present in the marginal and intermediate 
zones of the neocortex35. To test for defects in MGE-derived interneuron migration in the 
CtcfNkx-Cre embryos, we introduced the Cre-responsive Rosa-mTmG reporter gene that 
results in GFP expression upon Cre-mediated recombination (Fig. 5A). The number of 
GFP+ (Ctcf-null) MGE-derived cells were identified and counted in the E16.5 cortex of 
CtcfNkx-Cre and littermate controls. We found a significant decrease in the number of GFP+ 
cells in the CtcfNkx-Cre neocortex, consistent with either a defect in production by the 
MGE, survival and/or with a defect in tangential migration to the cortex (Fig. 5B,C). In 
support of a migration defect, the expression of Cxcr4 was significantly decreased in the 
CtcfNkx-Cre and CtcfNes-Cre E14 embryos, compared to controls (Fig. S4).  
 
Figure 7: Fewer CTCF-null MGE-derived cells reach their destination in the cortex. 
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Figure 5: Fewer CTCF-null MGE-derived cells reach their destination in the cortex. 
(A) Diagram depicting the Rosa-mTmG allele and the Cre-dependent recombination that 
results in a switch from red to green fluorescence. Orange arrows represent loxP sites.(B) 
Fluorescence microscopy of E16.5 cortical sections of the indicated genotypes after 
DAPI counterstaining (blue). Green fluorescence is evident in Cre+ cells originating from 
the MGE that are migrating tangentially in the cortex. Note that the red fluorescence 
channel is not shown. Scalebar,100 µm. Nkx-Cre control animals were used for this 
experiment (C) Quantification of the density of GFP+ cells (outlined in white in B), n=5 
controls, n=6 CtcfNkx-Cre. (D,F) Pv and Sst ISH in the cortex of P21 CtcfNkx-Cre mice and 
littermate controls (E, G). Quantification of the density of Pv+ cells (n=4 pairs) or Sst+ 
cells (n=3 pairs). Error bars represent SEM and asterisks indicate P<0.05, Student’s t-test. 
The extended survival of these mice compared to the CtcfNes-Cre allowed us to investigate 
the outcome of embryonic MGE abnormalities on cortical GABAergic interneurons at 
P21, a time at which cortical interneuron number and laminar position have attained adult 
patterns36. ISH of brain sections from control and mutant P21 mice revealed that the 
number of Pv+ and Sst+ interneurons in the CtcfNkx-Cre cortex is significantly reduced 
compared to controls, (Fig. 5D-G). We also examined the outcome of CTCF loss on 
laminar positioning of interneurons, by dividing a sampled cortical area into ten equal 
bins, with bin 1 corresponding to the most superficial of these (ie cortical layer I). This 
analysis showed that Sst+ and Pv+ cells in CtcfNkx-Cre cortices were reduced equally 
among lamina (data not shown). As MGE-derived interneurons occupy laminar layers 
based on developmental time, these findings suggest that Ctcf deletion affects MGE 
interneuron production equally over time. 
2.3.6 Deletion of Ctcf results in altered fate and distribution of MGE-derived cells 
To further evaluate the postnatal consequences of the transcriptional alterations of Lhx6 
and Lhx8 in the embryonic CTCF-null MGE, we investigated the relative proportion of 
interneuron subtypes as well as their respective cortical position at P21. Despite the 
observed reduction of Pv+ and Sst+ cells in the cortex, Gad1 ISH shows that the total 
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number of cortical GABAergic interneurons was not different (Fig. 6A,B). Moreover, we 
observed no difference in the number of Reelin+ interneurons, a gene expressed in a 
portion of interneurons originating from the MGE and the CGE (Fig. 6D,E). However, 
we find that Gad1+ interneurons in the CtcfNkx-Cre cortex tend to occupy upper cortical 
layers at the expense of deeper ones when compared to controls (Fig. 6C). This change in 
laminar distribution was also observed with Reelin+ interneurons (Fig. 6F).  
 
Figure 8: CTCF is required for final cortical lamination of interneurons 
Figure 6: CTCF is required for final cortical lamination of interneurons. ISH of P21 
cortices (A , D, G, I). Gad1 marks all cortical interneurons; Reelin marks a subset of 
MGE and CGE-derived interneurons; Vip and Calretinin (Cr) are markers of CGE-
derived interneurons. Quantification of cortical cell densities. Error bars represent SEM. 
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(C, F) Cell densities by cortical bin. Cortex was divided into ten horizontal bins, where 
bin 1 represents the most superficial and approximates the marginal zone. Two-way 
repeated measures ANOVA was significant for both Gad1 and Reelin. Student’s t-test 
was performed for each bin, and significantly different bins (P<0.05) are marked by 
asterisks (not corrected for multiple testing). 
As CGE-derived interneurons tend to occupy superficial layers, we hypothesized that 
there was aberrant specification of the MGE-derived cells into CGE-like cells. The latter 
scenario is supported by previous work showing that Lhx6 deletion in MGE-derived cells 
cause a fate switch to more CGE-like subtypes as determined by laminar distribution and 
marker expression19.  To test whether Ctcf-null MGE-derived cells adopt a CGE-like fate, 
we examined known markers of CGE-derived cortical interneurons (Vip, Cr and SP8) in 
P21 cortex of control and CtcfNkx-Cre animals. No significant difference in either total 
number (Fig. 6G-J, S5) or laminar position (data not shown) was observed, indicating 
that Ctcf-null MGE cells, despite expressing lower levels of Lhx6, do not ectopically 
express CGE markers. Taken together these data indicate that the Ctcf-null MGE cells 
that migrate tangentially into the cortex likely fail to laminate normally because of a 
radial migration defect. 
2.3.7 Forced Lhx6 expression in CTCF-null MGE-derived cells restores SST-expressing 
interneurons upon transplantation in the cortex of wildtype mice. 
The fate and migration defects of Ctcf-null MGE interneurons was further evaluated by 
viral-mediated labeling and transplantation of Ctcf-null or control MGE cells into 
wildtype host cortex, as previously described19,37. Briefly, the MGE was dissected from 
E13.5 CtcfNkx-Cre embryos or heterozygous littermate embryos (acting as controls). The 
MGE was dissociated and either transplanted directly into hosts or transduced with 
lentiviral constructs before transplantation (Fig. 7A). For phenotyping experiments, the 
MGE was dissected from CtcfNkx-Cre embryos carrying the Cre-sensitive Rosa-mTmG 
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reporter allele to label cells with GFP. The GFP-labelled MGE cells were then 
transplanted into wildtype host pups (P1). The brains were removed from transplant-host 
pups at P35 and cortical sections were examined by immunofluorescence microscopy.   
Immunofluorescence staining for SST revealed a marked reduction (~50%) in the number 
of transplanted CtcfNkx-Cre GFP+ cells expressing SST compared to control (Fig. 7B-E, R). 
Conversely, no changes were observed in PV-expressing cells (Fig. 7N-Q, T). We 
detected a significantly higher number of GFP+ transplanted cells in layer I (p < 0.0001), 
and a reduction in cortical layer V, similar to the laminar defects observed in the CtcfNkx-
Cre mice at P21 (Fig. 7U). Importantly, a striking increase in the number of transplanted 
CtcfNkx-Cre GFP+ cells that co-express LHX8 was detected (Fig. H-K, S). These GFP+/ 
LHX8+ cells remained close to the injection site (Fig. 8A,B), indicating that their 
migratory capacity was defective in the cortical environment, as opposed to GFP+/ 
LHX8- cells.  
We then asked whether the reduction of Lhx6 in CTCF-null MGE cells is the cause of the 
observed phenotypes. To test this, we re-expressed Lhx6 in the MGE transplants by 
transducing CtcfNkx-Cre MGE cells (not expressing the Rosa-mTmG reporter) with the 
lentiviral construct (Dlx)I12b–GFP–T2A–Lhx6, as previously described19 (refer to Fig. 
7A for schema). At P35, twice as many GFP+ transplanted cells that had been transduced 
with Lhx6 co-expressed SST (back to normal levels) compared to those transduced with a 
control vector lacking Lhx6 (Fig. 7R). The lamination defect of CtcfNkx-Cre transplanted 
cells was also rescued upon re-expression of Lhx6 (Fig. 7U). However, the proportion of 
GFP+/LHX8+ cells remained high upon forced expression of Lhx6, indicating that Lhx8 
upregulation is probably not a compensatory response to reduced Lhx6 levels, but is more 
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likely caused by a failure to repress gene expression in the absence of CTCF. Finally, we 
wanted to assess whether the number of transplanted cells was similar between 
genotypes. Thus, we counted the number of GFP+ cells observed for each group and 
normalized this number to the number of tissue sections used for analysis (Table S1). 
While the numbers varied between groups, there were trends towards less cells being 
detected in the CTCF cKO and Lhx6 rescued cells compared to controls, suggesting that 
some cells might be compromised in the CTCF cKO. 
2.3.8 CTCF-null MGE cells acquire a GABAergic projection neuron fate 
Many of the transplanted CTCF-null MGE cells that express LHX8 did not migrate into 
the cortex and remained close to the injection site (Fig. 8A,B). Since many LHX8+ cells 
are fated to become cholinergic striatal neurons, we examined whether they had gained 
expression of choline acetyltransferase (ChAT), a marker of cholinergic fate. Only a 
small proportion of the transplanted GFP+ cells co-expressed ChAT ( ~10.5%), most of 
which were located near or within the injection site (Fig. 8C,D,G,H). Fate mapping 
studies also indicate that approximately 60-70% of LHX8+ cells in the basal forebrain 
become GABAergic, instead of cholinergic18, prompting us to examine transplanted cells 
for co-expression of GABA. The results indicate that the majority of CTCF-null LHX8+ 
transplanted cells are GABAergic (Fig 8E,F).  
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Figure 9: Analysis of transplanted CTCF-null MGE cells and rescue by ectopic 
Lhx6 expression. 
Figure 7: Analysis of transplanted CTCF-null MGE cells and rescue by ectopic 
Lhx6 expression. (A) Schema depicting the MGE transplantation and rescue strategy. 
Briefly, CtcfNkx-Cre heterozygotes (cHets) or knockouts (cKO) were transplanted into P1 
WT neocortices and then assessed for cortical interneuron markers and laminar 
distribution. In addition, CTCF cKOs were transduced with a lentivirus expressing Lhx6 
and GFP, transplanted, and then assessed in the same manner. After 35 days, transplanted 
cells were assessed for GFP and SST (B-G), LHX8 (L-M) or PV (N-Q). Arrows denote 
co-labelled cells. Quantification of the proportion of GFP+ cells that co-express either 
SST (R), LHX8 (S), or PV (T). (U) Quantification of the proportion of GFP+ cells that 
occupy different cortical lamina. (IS) injection site. Data are expressed as the mean ± 
SEM. n= 3, all groups. **p < 0.01, ****p < 0.0001. Scale bar in (Q) represents 100 µm. 
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Figure 10: Specification of CTCF-null MGE cells to Lhx8+Gbx2+ GABAergic 
projection neurons of the globus pallidus. 
Figure 8: Specification of CTCF-null MGE cells to Lhx8+Gbx2+ GABAergic 
projection neurons of the globus pallidus. Transplanted CTCF-null MGE-derived cells 
that fail to migrate away from the injection site (IS) express LHX8 and ChAT (A-D) and 
LHX8+ cells co-express ChAT and GABA (E-H). An increased number of Lhx8+ and 
Gbx2+ cells migrate from the MGE to the globus pallidus in the CtcfNes-Cre E15.5 
embryonic brain (I-L). VZ/SVZ: ventricular and subventricular, FIM: fimbria, H: 
hippocampus, at: anterior thalamic nucleus, STT: stria terminalis, gp: globus pallidus. 
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GBX2 is a downstream effector of LHX8, and its expression marks either striatal 
cholinergic neurons (LHX8+, GBX2+, ChAT+) or GABAergic projection neurons of the 
basal forebrain (LHX8+, GBX2+, ChAT-)38. Indeed, upon further examination of the 
CtcfNes-Cre embryos at E15.5 by ISH, we observed more Gbx2+ and Lhx8+ cells that 
migrate radially from the MGE to the globus pallidus (Fig. 8E-H). Collectively, these 
results suggest that loss of Ctcf in MGE cells likely re-specifies a portion of LHX6+ 
GABAergic cells destined for the cortex to LHX8+ GABAergic projection neurons that 
migrate radially into the basal forebrain. 
2.4 Discussion 
The MGE generates a variety of different cell types including GABAergic cortical and 
striatal interneurons, GABAergic projection neurons (e.g. globus pallidus), cholinergic 
striatal interneurons, and cholinergic projection neurons16,39–41. The mechanism of genetic 
programming in the MGE that allows for this cellular diversity is the subject of intense 
research. The present study advances knowledge of these events by demonstrating that 
CTCF, a factor involved in higher order organization of chromatin structure, is required 
for fate specification of interneurons born in the MGE. Loss of CTCF alters the balance 
between GABAergic cells fated to become cortical interneurons versus basal forebrain 
projection neurons, through the regulation of LHX6 and LHX8 LIM homeodomain 
factors.  
Expression of Lhx6 and Lhx8 was altered upon Ctcf inactivation, while NKX2.1 remained 
unaffected, indicating that CTCF either acts downstream or in parallel with this factor. 
We found no evidence that CTCF interacts with NKX2.1 or co-occupies binding sites in 
E13.5 MGE chromatin around Lhx6 and Lhx8 gene loci. Alternate possibilities for 
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regulation must therefore be considered, such as loss of another NKX2.1 binding partner 
upon Ctcf deletion, or that CTCF is required to set up specific chromatin architecture 
permissive for NKX2.1 binding, without direct protein-protein interaction.   
Deletion of another genome organizer, Special AT-rich DNA Binding Protein 1 (Satb1), 
also impairs differentiation of SST+ interneurons43, confirming that chromatin 
organization is a key regulatory mechanism of cell fate specification and differentiation 
of MGE-derived cells. CTCF has been shown in other models to influence gene 
expression by modulating looping, topological chromatin domains, and enhancer-
binding44.  Additional studies will be required to precisely uncover how CTCF affects 
chromatin structure and gene expression in the MGE. 
Decreased expression of Lhx6 upon loss of Ctcf is associated with reduced number of 
SST+ and PV+ interneurons in the cortex. The effect on SST+ interneurons is directly 
caused by the reduced Lhx6 expression, since lentiviral transduction of Lhx6 in Ctcf-null 
MGE cells fully re-instated normal number of SST+ cells in transplantation experiments.  
Our transplantation studies failed to replicate a loss of PV+ interneurons seen in the 
CtcfNkx-Cre model. One possible explanation is a variable necessity for LHX6 expression 
in different mouse strains/ genetic backgrounds. For the transplantation experiments, Ctcf 
deletion was performed in a CD1 background to maximize litter size, whereas our P20-22 
CtcfNkx-Cre mice were generated in the C57BL/6 strain. Another possibility is that the PV+ 
interneurons that are lost in the genetic mouse model described herein are either born at a 
different age or may fail to migrate into the neocortex. Notably, we only transplanted 
E13.5 MGE cells, however, multiple PV+ subgroups are born over a long period of time. 
Moreover, while transplanted MGE cells can still migrate in the neocortex where they are 
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placed, they do not experience the same obstacles that endogenous MGE would while 
tangentially migrating into the neocortex.  It is possible that the cells fated to become 
PV+ may be more affected by migration than by fate, although this remains to be 
determined. Additionally, a similar phenomenon has previously been described in SST 
cell fate by Neves et al (2013)45 using a hypomorphic allele of Lhx6, which resulted only 
in loss of SST but not PV interneuron subtypes, in a C57BL/6 background. Together, 
with the work presented here, these data suggest that the role of LHX6 is stricter for 
SST+ subtype specification, and that its role in PV+ subtype specification may be 
compensated for in different genetic backgrounds.     
Lhx6-null MGE cells were previously found to undergo a partial fate switch to CGE-like 
cells19 but we failed to observe this in the CTCF-null MGE cells, indicating that only 
complete loss of Lhx6 expression leads to this switch to CGE-like fate. Lhx6 deletion 
models show defective tangential migration of interneurons into the cortex, which we 
also observed with deletion of Ctcf in the MGE. Reduced expression of the CXCR4 
chemoreceptor, whose expression is promoted by Lhx646, could contribute to this 
phenotype. By weaning age however, the mutants had the same number of cortical 
GABAergic interneurons, albeit with defective lamination. Since there was no difference 
in lamination of interneurons expressing CGE markers, this suggests the lamination 
defects of the GABAergic interneurons is a result of cell-autonomous effects of Ctcf loss 
in MGE-derived interneurons. This also appears to be a defect related to reduced Lhx6, as 
re-expression of Lhx6 in transplanted Ctcf-null cells corrected laminar positioning.  
Ctcf loss from MGE cells also causes increased expression of Lhx8, which provides a 
possible explanation for the increased number of GBX2+ cells in the basal forebrain in 
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the CtcfNes-Cre embryos. These cells likely represent basal forebrain GABAergic neurons 
that project to the cortex, as transplanted Ctcf-null cells co-expressed LHX8 and GABA, 
but few expressed ChAT or Nkx2.1. Re-expression of Lhx6 was not sufficient to reduce 
the number of LHX8+ cells to normal levels in transplants.  However, this could also be 
explained by reduced functionality of the DlxI12b enhancer to re-express Lhx6 in LHX8+ 
Ctcf-null cells.  
Understanding the molecular control switches in cell fate specification of MGE cells is 
relevant to the in vitro differentiation of these progenitors to specific neuron types and in 
the treatment of human neurological disorders12,47,48. The genetic pathways in MGE 
differentiation and specification are highly conserved between mouse and human49–51, 
therefore the molecular understanding of MGE development has direct influence on our 
ability to effectively generate MGE-derived cell subtypes from human stem cells.  In 
addition, understanding the role of CTCF in the developing brain could impact our ability 
to treat human disorders caused by CTCF dysregulation, as here we provide evidence that 
CTCF loss decreases Lhx6 expression and cortical GABAergic neurons. Mutation of one 
copy of CTCF in humans can result in intellectual disability21, ASD52 and conditions with 
altered GABAergic neuron function6,53. In addition, CTCF has been associated with 
schizophrenia24, which has also been linked with defects in LHX654. Our study implicates 
CTCF in fate specification of MGE progenitors and complements current efforts to 
understand MGE development from the perspective of chromatin regulators. 
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Figure 11: Early deletion of Ctcf from neuroprogenitors results in dysregulated 
expression of Protocadherin (Pcdh) clusters. 
Figure S1 (Related to Figure 1): Early deletion of Ctcf from neuroprogenitors 
results in dysregulated expression of Protocadherin (Pcdh) clusters. (A) Relative 
expression by RT-qPCR of Pcdh genes from clusters a, b, and g in CtcfNes-Cre, normalized 
to littermate-control set to 1, and to Gapdh. N=3, error bars represente mean +/- SEM. 
Asterisks indicate P< 0.05 using Student’s t-test. Not corrrected for multiple testing. Taf7 
and Diap1 are genes located between the Pcdh-b and Pcdh-g clusters. 
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Figure 12: CTCF expression is lost early in conditional knockouts but does not 
impact number of proliferative cells at peak interneuron-genesis. 
Figure S2 (Related to Figure 2): CTCF expression is lost early in conditional 
knockouts but does not impact number of proliferative cells at peak interneuron-
genesis.  (A) Immunofluorescence staining for CTCF (green) at E12.5 in CtcfNes-Cre 
coronal brain sections (Watson et al. 2014). Nuclei are counterstained with DAPI. 
Adjacent insets show CTCF is expressed in the MGE of control, but absent from the 
CtcfNes-Cre MGE by E12.5. (B) Lhx6 ISH in E12.5 rostral and caudal coronal sections. 
Tissue is outlined for ease of visualization. (C) Immunofluorescence staining for BrdU, 
marker of S-phase cells, one hour after BrdU injection of pregnant dam. Quantification of 
density of BrdU+ nuclei in E12.5 MGE VZ of control and CtcfNkx-Cre embryos (n=3). 
Error bars represent mean +/-SEM. In all panels, scalebar represents 100 µm. 
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Figure 13: CtcfNkx-Cre mice have low serum T4 levels.  
Figure S3 (Related to Figure 4) CtcfNkx-Cre mice have low serum T4 levels. (A) 
Quantification of serum T4 from P20-22 CtcfNkx-Cre mice and control siblings by ELISA. 
Error bars represent mean +/-SEM, (n= 6 pairs). Asterisk indicates P<0.05 by Student’s t-
test. 
 
Figure 14: Reduced expression of the Lhx6 downstream effector Cxcr4 in the CTCF-
null E14 telencephalon. 
Figure S4 (Related to Figure 5): Reduced expression of the Lhx6 downstream 
effector Cxcr4 in the CTCF-null E14 telencephalon. Quantitative RT-PCR was 
performed using Cxcr4 primers using RNA isolated from E14 telencephalon of CtcfNes-Cre 
or CtcfNkx-Cre embryos. Data was normalized to β-actin expression. Error bars represent 
mean +/-S.E.M. Asterisks indicate P<0.05, Student t-test. 
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Figure 15: Deletion of Ctcf does not promote fate switch to SP8+ interneuron 
subtype. 
Figure S5: Deletion of Ctcf does not promote fate switch to SP8+ interneuron 
subtype. (A) Immunofluorescence staining for SP8 (red) in P21 cortex, counter-stained 
with DAPI. Merged blue and red channels, and red channel alone are shown. Scalebar 
represents 100 µm. (B) Quantification of SP8+ cell density. Error bars represent mean +/-
SEM, n=6 pairs. P=0.383, Student’s t-test. 
 
Table S1: Number of GFP+ cells observed 35 days after MGE cell transplantation 
for each genotype 
Table 2: Number of GFP+ cells observed 35 days after MGE cell transplantation 
for each genotype 
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Table 3: Primer sequences used for genotyping, RT-qPCR, and ISH probe 
synthesis 
Table S2: Primer sequences used for genotyping, RT-qPCR, and ISH probe 
synthesis 
 
2.5 Materials and methods 
Mice and Genotyping 
Animal studies were approved by the University of Western Ontario Animal Care 
Committee according to guidelines established by the Canadian Council on Animal Care. 
Mice were housed in the London Regional Cancer Program vivarium (12 h light/dark 
cycle) and were provided with regular chow and water ad libitum. The Ctcfflox/flox mice 
were generated by Heath et al. (2008)55 on a C57BL/6 background. The NestinCre mice 
Gene (purpose) Forward Sequence Reverse Sequence 
Ctcf (genotype) CTAGGAGTGTAGTTCAGTGAGGCC GCTCTAAAGAAGGTTGTGAGTTC 
Sry (genotype) GCAGGTGGAAAAGCCTTACA AAGCTTTGCTGGTTTTTGGA 
Cre (genotype) TGACCAGAGTCATCCTTAGCG AATGCTTCTGTCCGTTTGCC 
Puma (genotype) AGGCTGTCCCTGCGGTCATCC WT:  
GGACTGTCGCGGGCTAGACCCTCTA 
MUT:  ACCGCGGGCTCCGAGTAGC 
Rosa mTmG 
(genotype) 
CTCTGCTGCCTCCTGGCTTCT 
 
WT: CGAGGCGGATCACAAGCAATA 
MUT: TCAATGGGCGGGGGTCGTT 
Ctcf (qPCR) CGATATGCTCTCATCCAGCA TCCCACACTTGGAACAGACA 
Lhx6 (qPCR) CTTGGGCTGACTGTCCTGTT GGTGCGGCAGACAAATCTAT 
B actin (qPCR) CTGTCGAGTCGCGTCCACCC ACATGCCGGAGCCGTTGTCG 
Lhx8 (qPCR) CCACCCATGTTGGAAGAAAT CATTGGATGGGGTAACAAGG 
Cxcr4 (qPCR) GAAGTAGATGGTGGGCAGGA 
 
ACGGCTGTAGAGCGAGTGTT 
Sst (qPCR) GGGCATCATTCTCTGTCTGG 
 
GAGGCAAGGAAGATGCTGTC 
Lhx8 (probe) GAAGAGCGATCAGATGTTTGTG 
 
TAATACGACTCACTATAGGGCACCTGT
ATGACACGTCTGCTT 
Pvalb (probe) GGATGTCGATGACAGACGTG TAATACGACTCACTATAGGGACTCAAC
CCCTTCCCTTCC 
Sst (probe) TGAAGGAGACGCTACCGAAG 
 
TAATACGACTCACTATAGGGAGGGTC
AAGTTGAGCATCG 
Gbx2 (probe) GATGAAGAGAAGCTAGAGCCCC TAATACGACTCACTATAGGGAGGTTCA
GATCCTGTGACTTCC 
Gad1 (probe) GGGACCCTTGAACCGTAGAG TAATACGACTCACTATAGGGCCCGTAC
TTCAGGGTGTCTC 
Cr (probe) GATGCTGACGGAAATGGG TAATACGACTCACTATAGGGCCCTACC
AGCCACCCTCT 
VIP (probe) CCTGGCATTCCTGATACTCTTC TAATACGACTCACTATAGGGATTCTCT
GATTTCAGCTCTGCC 
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(C57BL/6 background) were previously described56. Bbc3/Puma-/- (stock #011067), 
Nkx2.1Cre (stock #008661) and RosamTmG (stock #007576) mice were purchased from the 
Jackson Laboratory. Mice carrying RosamTmG are of a mixed background and were bred to 
Ctcfflox/flox mice to homozygosity.  
Ctcfflox/flox and NestinCre were mated and the NestinCre+ offspring were time-mated with 
Ctcfflox/flox to generate CtcfNes-Cre conditional knockout embryos (CtcfNes-Cre), as done 
previously27.  CtcfNes-Cre embryos exhibit efficient Cre-mediated recombination at loxP 
sites flanking exons 3 to 12 of the Ctcf locus in neuroprogenitors beginning at about 
E1127. Embryos without the NestinCre transgene and wildtype Ctcf expression were used 
as controls.  
CtcfNkx-Cre mice were generated in the same fashion as CtcfNes-Cre animals. Nkx2.1Cre+ 
mice were maintained on a C57BL/6 background, with the exception of the transplant 
experiments which were performed using Nkx2.1Cre+ mice maintained on a CD1 
background. For these mice, care and procedures were performed according to the 
University of California at San Francisco Laboratory Animal Research Center guidelines.  
For timed matings, time of conception was arbitrarily designated as the midnight before 
vaginal plug discovery. To label proliferative cells, pregnant dams were injected 
intraperitoneally with BrdU labelling agent (GE Healthcare Life Sciences) at 1 mL/ 100g 
body weight, as previously described, 1 h prior to sacrifice27.  
P20 mouse brains were harvested after transcardial perfusion with 20 mL PBS (DEPC-
treated) followed by perfusion with 20 mL 4% paraformaldehyde (PFA)/PBS (DEPC-
treated) before brain dissection.  
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RNA-sequencing analysis   
Telencephalons of two E14 CtcfNes-Cre embryos and littermate controls (Ctcf flox/ flox) were 
processed for RNA-seq at Otogenetics. Raw reads were aligned to mouse genome mm10 
using STAR57 version 2.5.3a with GENCODE M11 primary annotations. Count matrices 
were generated using the R GenomicAlignments package58 and normalized using 
DeSeq259. Low expressing genes (counts less than 2% of the average of all samples) were 
removed and genes with an average fold change of 1.5 fold or greater were used for 
downstream analysis by The Protein ANalysis THrough Evolutionary Relationships 
(PANTHER) (http://pantherdb.org/).  
Quantitative RT-PCR analysis 
For RT-qPCR, total RNA was extracted using an RNeasy Mini kit (Qiagen) and cDNA 
was synthesized using SuperScriptTM II Reverse Transcriptase (Invitrogen), as previously 
described27.  Primer sequences used for qPCR are listed in Table S2. All primers in this 
study were designed using Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/primer3/). 
PCR amplification was performed using iQ SYBR Green supermix (Bio-Rad) under the 
following conditions: 95˚C for 3 mins, [95˚C for 10 s, 58˚C for 20 s, 72˚C for 30 s]x35, 
72˚C for 5 mins. A melting curve for each sample was generated from 55°C to 95°C in 
increments of 1°C and PCR products were run on agarose gel to verify band size. β-actin 
was quantified and used for normalization of the data.    
Immunofluorescence (IF) and in situ hybridization (ISH) staining  
Dissected samples were incubated in 4% PFA/PBS (DEPC-treated) overnight, then 
dehydrated in 30% sucrose until samples sank to the bottom, before being frozen in 
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cryomatrix (OCT) and sectioned at 8 µm thickness. IF and BrdU labelling was performed 
as previously described27. For IF, slides with sections were re-hydrated in PBS then 
incubated overnight (8-16 h) with the primary antibody at 4°C in 0.3% Triton X-100 in 
PBS at the following dilutions: rabbit anti-CTCF (1:400; Cell Signaling Technology), 
mouse anti-BrdU (1:50; BD Biosciences), rabbit anti-NKX2.1 (1:100; Santa Cruz) and 
goat anti-SP8 (1:100; Santa Cruz). For BrdU, tissue sections were treated with 2N HCl, 
then 0.1 M Na2B4O7, pH8.5, before primary antibody incubation. For anti-SP8 staining, 
slides were heated in 10 mM sodium citrate, then blocked with 10% NGS/ 0.3% Triton 
X-100 in PBS for 1 hour before incubation with the primary antibody. The following 
morning, sections were washed with 0.3% Triton X-100 in PBS and incubated with the 
corresponding secondary antibody (1:800 Alexa 594 or 488; Invitrogen) for 1 h. Sections 
were then washed again and stained with DAPI (Sigma-Aldrich).  
ISH riboprobes were synthesized as follows, with the exception of the Reelin ISH probe, 
which was a kind gift from the Rubenstein lab; Template DNA was PCR amplified using 
primers, where the reverse primer was labelled with the T7 recognition sequence at the 5’ 
end (Table S1). Digoxigenin-labelled riboprobes were then synthesized from the gel 
purified template DNA using T7 (antisense probe) polymerase (Roche) according to the 
manufacturer’s instructions. For ISH, sections were incubated overnight (12-18 h) with 
antisense digoxigenin-labelled riboprobes at 65°C in a humidified chamber. Riboprobes 
were diluted in formamide-based hybridization buffer at 1:1000 from stock. The 
following morning, sections were washed in formamide-based ISH wash buffer, then 
maleic acid buffer containing Tween 20 (MABT) before incubation with alkaline 
phosphatase conjugated anti-Digoxigenin Fab fragments (Roche) overnight. Excess 
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antibody was removed with a series of MABT and prestaining-buffer washes, before 
riboprobe detection using the NBT/BCIP system (Roche) in a polyvinyl alcohol-based 
solution. After staining, the reaction was ended with vigorous PBS washing. Sections 
were cleared by dehydration in serial ethanol dilutions (70%, 90%, 100%) and xylene, 
then mounted.    
Microscopy and imaging 
Fluorescence and light microscopy was performed using an inverted (DMI 6000b) Leica 
microscope. Light microscopy was also performed with the Aperio CS2 digital pathology 
scanner (Scanscope; Leica). For transplant experiments, fluorescent images were taken 
using a Coolsnap camera (Photometrics) mounted on a Nikon Eclipse 80i microscope 
using NIS Elements acquisition software (Nikon). Images were processed with Volocity 
(PerkinElmer), Imagescope (Leica), ImageJ and Adobe Photoshop.   
Co-immunoprecipitation and Western blot analysis 
Total protein was extracted from embryonic telencephalon or MGE, using standard 
protocol with RIPA buffer, and quantified with the Bradford assay. For 
immunoprecipitation, E13.5 MGE were pooled from wildtype embryos, the protein was 
incubated overnight with either anti-CTCF, anti-NKX2.1 or IgG antibody (mock IP). 
Antibody-protein complexes were incubated with protein-G Dynabeads and isolated by 
centrifugation. After washing, interactions were disrupted and proteins were detected by 
Western blotting as below.  
Protein lysates were resolved on an 8% SDS-polyacrylamide gel and transferred to a 
nitrocellulose membrane. Anti-CTCF (1:1000; Cell signalling), anti-NKX2.1 (1:2000; 
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Santa Cruz) and anti-β-ACTIN (1:7000; Sigma Alderich) were used to probe the 
membrane, followed by secondary detection with the corresponding horseradish 
peroxidase-conjugated antibodies (1:4000; GE Healthcare Life Sciences). Protein was 
quantified using ImageJ software (version 1.47).  
ChIP sequencing   
ChIP in MGE was performed as previously described for mouse forebrain27. E13.5 MGE 
was dissected and pipetted up and down in DMEM to create a single cell suspension. 
Cells were fixed in 1% formaldehyde, then lysed in SDS buffer. Chromatin was sonicated 
to an average size of 500 bp, then 1/25 of total chromatin was set aside (input). The rest 
of the chromatin was incubated overnight with rabbit anti-CTCF antibody (Cell Signaling 
Technology) or rabbit IgG, as a control. CTCF-bound chromatin fragments were then 
purified using magnetic Dynabeads (Invitrogen), and crosslinking was reversed. ChIP-
seq reads were aligned to mouse genome mm9 or mm10 using Bowtie260 version 2.3.2 
using default settings. Peaks were called using MACS261 version 2.1.1.20160309 with 
P=0.001. Wig files were generated using deepTools62 and overlapping peaks were 
identified using Bedtools63.  
T4 ELISA 
Blood was collected from P20 mice by trans-cardiac puncture using an EDTA-coated 
syringe (pH 7.0). Blood was centrifuged for 10 minutes (14,000 RPM) at 4˚C, then the 
plasma collected and stored at -20˚C. Plasma was loaded onto the T4 ELISA kit 
(Calbiotech, T4044T-100) according to manufacturer protocols.   
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Cell Counts 
To determine the density of marker-positive cells, 5 to 10 serial cryosections (8 µm 
thickness) were evaluated in a blinded manner. Areas within the indicated brain regions 
were calculated (mm2) from microscope images in Volocity or Imagescope softwares and 
counts were performed in a blinded manner. For counts performed in P20-22 cortex, the 
cortex was divided into 10 equal-sized horizontal bins to simultaneously determine 
laminar changes. The first cortical bin location and size corresponds approximately to the 
marginal zone.  
Cloning 
The DlxI12b-GFP-T2a-Lhx6 vector19 was modified to remove loxP sites that flanked the 
expression cassettes. PCR was used to generate a DlxI12b-GFP fragment that harbored a 
5’ XbaI restriction enzyme site, but excluded the loxP site from the original vector, and a 
3’ primer against GFP that included a BsrGI site. This product was then ligated into the 
same backbone in the 5’ XbaI and 3’ BsrGI sites. The resulting vector lacked a flanking 
loxP site and could be expressed in cells expressing Cre recombinase. Vectors were 
verified by restriction digest and sequencing.  
Lentiviral generation 
HEK293T cells grown in DMEM H21 with 10% FBS were transfected using 
Lipofectamine2000 (Thermo Fisher) with the lentiviral expression vector and three helper 
plasmids (pVSV-g, pRSVr and pMDLg-pRRE) to generate lentivirus particles as 
previously described19. Media containing lentiviruses was collected after four days and 
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filtered through a 0.45 low protein binding membrane to remove cells and large debris. 
The filtered media was pooled and ultracentrifuged at 100,000 x g for 2.5 hours at 4°C. 
The supernatant was removed and the pellet was resuspended overnight at 4°C in sterile 
PBS then stored at -80°C until use. 
MGE transplantation 
MGE transplantation and rescue assays have been previously described19. Briefly, E13.5 
MGE tissue from either Ctcf flox/wt:NestinCre (controls) or Ctcf flox/flox:NestinCre (KO) 
embryos were harvested and dissociated into a single cell suspension before injection into 
a WT P1 host. For rescue experiments, MGE cells from Ctcf flox/flox:NestinCre (KO) 
embryos were collected in the same manner and then incubated with lentiviruses that 
expressed Lhx6 and GFP for 30 minutes at 37°C in media at physiological pH before 
transplantation. Transplanted cells were allowed to develop in vivo for 35 days before 
analysis. Immunofluorescence staining of sections at day 35 were performed with the 
following antibodies: rabbit anti-GFP (Clontech, 1:2000), or chicken anti-GFP (Aves, 
1:2000), rabbit anti-PV (Swant, 1:500), or mouse anti-PV (Millipore, 1:500), rat anti-SST 
(Millipore, 1:200), guinea pig anti-Lhx8 (generous gift from Aleksandar Rajkovic, 
University of Pittsburgh). 
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Chapter 3 
3 Brain dysmorphology and sexually dimorphic behaviour impairments 
induced by embryonic CTCF haploinsufficiency  
Elbert, A.1,2, Levy, M.1,2, Watson, L.A. 1,2, Schmid, S.3, Lerch, J.4, Bérubé, N.G.1,2,* 
Affiliations: 1Children’s Health Research Institute, London, Ontario, Canada. 
2Department of Paediatrics, Schulich School of Medicine and Dentistry, the University of 
Western Ontario, Victoria Research Laboratories, London, Ontario, Canada. 3Department 
of Anatomy and Cell Biology, 4Department of Medical Biophysics, University of 
Toronto, Mouse Imaging Centre, Hospital for Sick Children, Toronto, ON, Canada. 
3.1 Abstract 
Genetic variation in CTCF, a ubiquitous chromatin organizer, is associated with 
increased risk for schizophrenia, while de novo mutation or deletion of one allele results 
in a dominantly-inherited intellectual disability syndrome with autistic features (OMIM 
#615502). To model human CTCF haploinsufficiency, we generated mice with Cre-
mediated deletion of a single copy of Ctcf in the embryonic brain. An early and 
progressive transcriptional compensation by the wildtype allele was observed in the brain 
of these mice, with CTCF levels reaching near control levels in adulthood. Despite 
nominal CTCF reduction, Magnetic Resonance Imaging (MRI) revealed changes in adult 
brain volume of limbic system structures and cerebellum. CtcfNestinhet mice exhibited 
delayed spatial learning and hyperactivity. Male, but not female CtcfNestinhet mice had 
differences in anxiety and social behaviours, compared with controls. These findings 
suggest that a minor decrease in CTCF protein levels in the developing brain can lead to 
important morphological and behavioural defects in adulthood, in a sex-specific manner. 
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3.2 Introduction 
CTCF encodes an 11 zinc-finger DNA-binding protein that functions in chromatin higher 
order organization, often with the cohesin complex1. The interaction of CTCF with itself 
and its protein partners mediates chromatin loop formation, which creates topologically 
distinct regions in the genome. This epigenetic process regulates the level and timing of 
gene expression across development2. 
Deletion of both copies of Ctcf is believed to cause embryonic lethality in humans3, but 
mutation or deletion of a single copy of CTCF leads to intellectual disability (ID), 
microcephaly, and growth retardation (MIM #615502).  Gregor and colleagues identified 
four children with varying levels of ID carrying de novo changes to one copy of the 
CTCF locus4. A recent report described an ID patient with a previously uncharacterized 
frameshift mutation in CTCF5.  
CTCF has also been linked to schizophrenia6 and autism spectrum disorder (ASD)7, 
which have overlapping clinical features and may have shared etiological pathways that 
are neurodevelopmental in origin8–10.  Features of schizophrenia include hallucinations, 
delusions, social impairments, alogia, abnormal motor behaviour and disorganized 
thinking11. A large body of evidence supports a pathophysiological model for 
schizophrenia in which developmental and genetic vulnerabilities interact with secondary 
environmental insults during critical periods of brain development12. Schizophrenia 
mouse models are reported to model the disorder in three areas: i) positive symptoms (eg 
spontaneous hyperactivity), ii) cognitive impairment (eg impaired re-learning), and iii) 
negative symptoms (eg social impairments)13.  These mice often have altered behaviour 
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in open field, MWM with reversal, Y-maze, prepulse inhibition and acoustic startle, and 
social investigations13,14. 
ASD is characterized by deficits in social-emotional reciprocity, communication and 
adaptive behaviours, and an increase in restricted, repetitive patterns of behaviour, which 
may or may not be accompanied by intellectual impairment11. ASD mouse models often 
show increased digging, which manifests in marble burying assays, as well as reduced 
sociability and vocalization, among other features15. 
Given the growing evidence for a role for CTCF in neurodevelopmental disorders, mouse 
models of CTCF loss were generated to investigate its function in the brain. Our group 
has shown that deletion of Ctcf in embryonic neuroprogenitors results in microcephaly, 
caused by aberrant proliferation resulting in premature depletion of the neuroprogenitor 
pool16.  Hirayama and colleagues have shown that deletion of Ctcf in neurons causes 
altered dendritic arborisation, reduced spine density and disorganized barrel cortices, 
indicative of impaired somatosensory mapping17. Another group created mice with 
conditional inactivation of Ctcf in excitatory neurons18. Mutant mice exhibited impaired 
learning and memory in the MWM paradigm and these findings were replicated by viral-
mediated depletion of Ctcf in the hippocampus. These conditional knockout mice had 
normal sociability but had no preference for a novel versus familiar mouse.  
Notwithstanding these recent contributions, the effect of haploinsufficiency for CTCF on 
the brain has not been addressed in a model system. In this study, we characterized mice 
with deletion of one copy of Ctcf in the developing brain. Despite the heterozygosity at 
the locus, we observed near control levels of CTCF protein in the adult brain, due to 
114 
 
compensation from the remaining allele. We find that the brain structure in these 
CtcfNestinhet mice is grossly altered and that these mice display abnormal behaviours that 
are more severe in, or unique to, the male mutant mice.   
3.3 Results 
3.3.1 Evidence of allelic compensation in the brain of CtcfNestinhet mice. 
We generated mice that model CTCF haploinsufficiency in the developing brain through 
crossing Ctcf flox/ flox animals to the NestinCre driver line. Both male and female 
CtcfNestinhet mice are viable and fertile (data not shown). To verify that the level of CTCF 
expression was halved in the mutant mice, we performed RT-qPCR and Western blot 
analysis of embryonic and adult brain tissue.  However, we observed levels exceeding 
50% in E14.5 and E16.5 forebrain samples.  The reduction in Ctcf expression only 
reached statistical significance in E13.5 wholebrain (Fig. 1C).  Levels of Ctcf mRNA and 
protein were also not significantly altered in adult cortex (Fig. 1A, C). Hippocampal 
tissue from the adult CtcfNestinhet mice showed an average CTCF protein level that was 
82% of control (P=0.343). Adult male cerebellum and cortical samples had, on average, 
comparable CTCF levels to those of control (94%), indicating substantial compensation 
from the wildtype locus. 
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Figure 16: CTCF expression in CtcfNestinCre brain suggests significant compensation 
from the wildtype allele. 
Figure 1: CTCF expression in CtcfNestinCre brain suggests significant compensation 
from the wildtype allele. (A) Representative western blot of CTCF in three control (Ctrl) 
and CtcfNestinCre (Het) adult sibling pairs from hippocampus (hippo), cortex, and 
cerebellum (cereb) to show inter-individual variability. β-ACTIN was used as a loading 
control for quantification in n=6 pairs, on the right. (B) Representative western blot of 
CTCF in E14.5 and E16.5 telencephalon, with quantification on the right, normalized to 
β-ACTIN (E14.5 n=2 pairs; E16.5 n=3 pairs). (C) RT-qPCR of Ctcf in E13.5 whole 
brain; E18.5 telencephalon, diencephalon, midbrain, and hindbrain; and adult cortex, 
normalized to β-actin. For all graphs, error bars represent SEM. 
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3.3.2 CtcfNestinhet and NestinCre control mice are smaller and display hind-limb clasping compared to 
Cre-negative controls 
We measured the weight of control and mutant mice from weaning until 10 weeks of age.  
We found that at 3 weeks of age, there was already a significant difference in weights 
between genotypes (Fig. 2B; P= 0.0046 by ANOVA); CtcfNestinhet male mice and 
NestinCre controls weighed less than Cre-negative control counterparts, and this 
discrepancy increased across the 7 week period.  Females showed a similar trend, but the 
effect of carrying the NestinCre gene was less pronounced. The size difference between 
NestinCre controls and CtcfNestinhet mice across 3 to 10 weeks of age was negligible, 
indicating that the reduced size of CtcfNestinhet mice is a consequence of NestinCre 
expression and not a reduction in CTCF levels.  
Paw-clasping, typically in the hind-limbs, is associated with abnormal neurological 
function, in particular due to cerebellar lesions, but also due to defects in the basal 
ganglia and cortex19.As a crude measure of neurological function, we tested CtcfNestinhet 
and control siblings for hind-limb clasping. An increased proportion of CtcfNestinhet and 
NestinCre mice exhibit hind-limb clasping compared to the others (Fig. 2A), suggesting 
again that this effect was mediated by the NestinCre transgene. 
3.3.3 Reduced brain volume in adult CtcfNestinhet mice  
We next examined whether we could detect morphological defects in the brain using 
high-resolution ex-vivo MRI combined with automated image analysis. These analyses 
revealed widespread reductions in brain volumes of both male and female CtcfNestinhet 
mice compared to controls, at 5-6 months of age (CtcfNestinhet, n=27, sibling controls, 
n=30; Fig. 3A-B).These reductions in volume appear to be consistent with what others 
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report with the NestinCre transgene. Therefore we analyzed brain volumes as relative 
volumes to Cre-negative controls. Genotype by sex interactions did not survive multiple 
testing, therefore genotypes are sub-grouped by sex only for total brain volume.  
 
Figure 17: CtcfNestinCre and NestinCre control mice are smaller and develop hind-limb clasping. 
Figure 2: CtcfNestinCre and NestinCre control mice are smaller and develop hind-limb 
clasping. (A) Proportion of CtcfNestinCre mice (orange line; n= 16 males, n= 7 females), 
NestinCre+ siblings (gold line; n= 4 males, n= 2 females), Ctcff/w siblings (blue line; n= 
14 males, n= 4 females), and wildtype siblings (silver line; n= 7 males, n= 14 females) 
that show hind-limb clasping on at least three occasions, over 7 weeks. (B) Weight of 
CtcfNestinCre mice (n= 20 males, n= 8 females), NestinCre+ siblings (n= 12 males, n= 7 
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females), Ctcff/w siblings (n= 17 males, n= 9 females), and wildtype siblings (n= 12 
males, n= 15 females) over 7 weeks. Error bars represent SEM.  
 
Figure 18: CtcfNestinCre mice have altered brain anatomy on MRI 
Figure 3. CtcfNestinCre mice have altered brain anatomy on MRI. For all image panels, 
blue depicts relative decreases, and red represents relative increases, from averaged MRI 
data acquired in CtcfNestinCre (n= 11 males, n= 16 females) compared with control siblings 
(n= 15 males, n= 15 females). For all graphs, the CtcfNestinCre genotype is denoted by “H” 
and control by “C”. (A) Representative sagittal (rows 1) and coronal (rows 2-3) slices, 
and adjacent quantification of total brain volume by genotype and sex. (B) Representative 
axial slice at the level of the anterior commissure (relative brain volume) with 
quantification of the pars anterior (yellow arrow) and posterior (white arrow) of the 
anterior commissure volume by genotype (normalized). (C) Deep cerebellar nuclei 
(relative brain volume) with adjacent quantification (D) Representative coronal slice at 
the level of the corpus callosum (relative brain volume). Quantification for relative brain 
volume was not available. (E) Representative coronal slice showing relative increase in 
volume at the level of the anterior lobules of cerebellum (absolute brain volume) in the 
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CtcfNestinCre, with adjacent quantification (normalized). (F) Representative coronal slice 
(absolute brain volume) showing relative increase in volume of the hippocampal dentate 
gyri in the CtcfNestinCre. Quantification was not available.    
 
We measured a marked reduction in the normalized volume of the anterior commissure 
(q-value F-statistic= 7.4 x 10
-9, Fig. 3B), the white matter tract connecting the two temporal 
lobes and orbitofrontal areas, which also contain decussating fibres from the olfactory 
tracts20.  Defects in the anterior commissure are consistent with reduced inter-
hemispheric connectivity. 
There are three sets of deep cerebellar nuclei in mice: the dentate, the fastigial and the 
interposed nuclei. When examining for focal changes in volume, there was a striking 
decrease in size of the dentate and fastigial deep cerebellar nuclei, when normalized to 
total brain volume (Fig. 3C). In addition, there were focal volume increases of the 
anterior lobes (lobules 4-5) of the cerebellum (Fig. 3E) and in the dentate gyrus of the 
hippocampus (Fig 3F) in the CtcfNestinhet brain. 
3.3.4 Abnormal behaviours are observed in CtcfNestinhet mice 
Human cases with mutations in one allele of the CTCF locus have intellectual disability, 
and some develop features of ASD. To evaluate how having a single copy of Ctcf affects 
adult mouse behaviour, 12 week-old male and female CtcfNestinhet mice were subjected to 
a battery of behavioural tests over a 5-week period and compared with Ctcf flox/ wildtype 
sibling controls. The open field test was used to detect abnormalities in exploration 
behaviour and activity over a two-hour period in low light conditions.  When male and 
female CtcfNestinhet mice were analyzed together, this genotype was significantly 
associated with hyperactivity, with the CtcfNestinhet mice showing a lot more variability 
than sibling controls (P=0.0345, Fig. 4A). When analyzed by sex, the hyperactivity was 
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more pronounced in males than females, but was not statistically significant (P=0.0711 
males only, Fig. S1A; P=0.2665 females only Fig. S1B). 
In the MWM, a test of spatial learning and memory, there was a significant delay of 
CtcfNestinhet mice to get to the platform (ANOVA P= 0.0077; Fig. 5A). When post-hoc 
per-day analysis was performed, this effect was driven by the delay to platform on Day 2 
of training (P= 0.0009). There was no defect in MWM reversal, suggesting that 
CtcfNestinhet mice do not have altered cognitive flexibility or re-learning deficit (Fig. S2B-
C). Both short-term memory (Day 5) and long-term memory (Day 12) were intact, with 
no significant difference between CtcfNestinhet mice and controls (Fig. 5B-E). We also 
tested motor learning using the rotarod (Fig. S2D-E) and working memory in the Y maze 
but found no significant difference between CtcfNestinhet and control mice (Fig. 5F-G).  
Deficits in sensory gating, measured by prepulse inhibition in mice, are frequently 
observed in schizophrenia21 and relevant mouse models13. Due to the association between 
CTCF and schizophrenia6, we began by testing the startle reflex to an acoustic stimulus 
of 105-115 db. This reflex involves the anterior cingulate cortex, the amygdala, the 
hippocampus, and the bed nucleus of the stria terminalis22. The strength of the startle was 
larger in CtcfNestinhet mice, although it did not reach statistical significance (male and 
female combined, P=0.0550; Fig. 6A). We observed prepulse inhibitions of 48-75% of 
the startle response, which is typical for these settings, and there was no statistically 
significant difference between the CtcfNestinhet and control mice (Fig. 6B-C). These results 
indicate that CtcfNestinhet do not have any abnormalities in the filtering and processing of 
sensory information. 
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Since CTCF mutations can cause ASD7, we tested for stereotyped and repetitive 
behaviours. There were no significant differences in the number of marbles buried 
between the CtcfNestinhet and controls (P-value= 0.355, Fig. 8A). There was also no 
significant difference in the time spent digging or grooming, during the social approach 
test (Fig. 8B).  
 
Figure 19: CtcfNestinCre mice are hyperactive, and male CtcfNestinCre mice have reduced anxiety, compared to control siblings. 
Figure 4: CtcfNestinCre mice are hyperactive, and male CtcfNestinCre mice have reduced 
anxiety, compared to control siblings. For all graphs, error bars represented SEM and 
horizontal bar represents the mean. (A) Distance travelled by CtcfNestinCre (het; n= 18 
females, n= 17 males) and controls (ctrl; n= 17 females, n= 16 males) in the open field 
test, totalled across 24 five-minute intervals, analyzed by repeated-measures ANOVA. 
(B) Time spent in the centre of open field enclosure by male CtcfNestinCre (het) and 
controls (ctrl), totalled across the same 24 five-minute intervals, analyzed by repeated-
measures ANOVA. (C) Time spent in closed and open arms of the elevated plus maze, 
analyzed by Student’s t-test. (D) Average number of arm entries in the elevated plus 
maze. (E) Average distance travelled in the elevated plus maze. 
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Figure 20: CtcfNestinCre mice have delays in spatial learning but impairments in short and long-term memory.   
Figure 5. CtcfNestinCre mice have delays in spatial learning but no impairments in 
short and long-term memory.  For all graphs, error bars represent SEM. (A) Latency to 
target platform in MWM of CtcfNestinCre (het) and controls (ctrl) over four training days. 
Repeated-measures ANOVA across training days was significantly different between 
genotypes. Post-hoc per-day Student’s t-test was significant for day 2, as denoted by †. 
(B-E) Proportion of time spent in each quadrant (target= T, opposite=O, left= L, right= 
R) on day 5 (short-term memory test) and day 12 (long-term memory test) of MWM. (F-
G) Percentage of spontaneous alternations in the Y-maze, where one alternation consists 
of consecutive entry into the three different arms, analyzed by Student’s t-test. 
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Figure 21: Figure 6. CtcfNestinCre mice have normal sensory gating. 
Figure 6. CtcfNestinCre mice have normal sensory gating. The CtcfNestinCre genotype is 
denoted by “het”, and control by “ctrl”. For all graphs, error bars represent SEM and 
horizontal bar represents the mean. (A) Quantification of the acoustic startle response by 
genotype and sex, analyzed by Student’s t-test. (B-C) Averaged prepulse inhibition for 
four conditions generated by varied interstimulus intervals (30 ms or 100 ms) and 
prepulse intensity (75 db or 80 db). Startle response for trials types is expressed as a 
percentage of the normalized “pulse only” trial in (B) males and (C) females. Results 
were analyzed by ANOVA. 
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Figure 22: Male CtcfNestinCre have decreased sociability and altered aggression behaviour. 
Figure 7:  Male CtcfNestinCre have decreased sociability and altered aggression 
behaviour. The CtcfNestinCre genotype is denoted by “het”, and control by “ctrl”. For all 
graphs, error bars represent SEM and horizontal bar represents the mean. (A) Interaction 
time of mice conspecific for genotype and sex in the social approach test, analyzed by 
Student’s t-test. The arrow indicates a significant outlier, which was not included in the 
analysis. (B-E) Time spent in chambers with stranger mouse or novel object by genotype 
in females (B) or males (D) in the social choice paradigm. The sociability index for each 
mouse was calculated as the time spent in the stranger mouse chamber, divided by the 
total time in the stranger mouse and novel object chambers. The average sociability index 
by genotype is shown for females (C) and males (E), and compared by Student’s t-test. 
(F) Latency to attack in the resident-intruder paradigm. Resident mice that did not attack 
in the assay have a default latency of 600 s, the total length of the interaction. Latency to 
attack was compared between genotypes by Student’s t-test. The number of attackers and 
non-attackers between genotypes was compared by Fisher’s exact test. (G-H) Correlation 
between difference in intruder mouse weight and resident mouse weight of controls (G) 
and CtcfNestinCre (H) and latency to attack. Regression lines are plotted with corresponding 
equations and correlation coefficients (r2).  
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Figure 23: CtcfNestinCre do not have stereotyped or repetitive behaviours. 
Figure 8: CtcfNestinCre do not have stereotyped or repetitive behaviours. The 
CtcfNestinCre genotype is denoted by “het”, and control by “ctrl”. For all graphs, the 
horizontal bar represents the mean. (A) Number of marbles hidden in the marble bury 
assay, grouped by genotype and sex, and analyzed by Student’s t-test (B) Time spent 
grooming or digging during the social approach assay, grouped by genotype and sex, and 
analyzed by Student’s t-test.   
3.3.5 Anxiety, sociability and aggressive behaviour were observed in male CtcfNestinCre mice. 
We found that male mutant mice, but not the females, showed defects in a subset of 
behaviours.  For example, male Ctcf Nestinhet mice spent more time in the centre of the 
enclosure in the open field, a measure that is associated with decreased anxiety 
(P=0.0243, Fig. 4B).  Consistent with this, male CtcfNestinhet mice also spent significantly 
more time in the open arms of the elevated plus maze, another finding suggestive of 
decreased anxiety (P= 0.0096, Fig. 4C). These measures of anxiety were not significantly 
different between female Ctcf Nestinhet mice and sibling controls (Fig. S1C-D).  
In the social approach test, pairs of unfamiliar mice with the same genotype (conspecific) 
are placed in a neutral cage and their interactions are observed. This test allows for the 
quantification of high quality social interactions. There was no statistically significant 
difference in quality of social interactions between CtcfNestinhet mice and controls, 
although male CtcfNestinhet tended to spend more time sniffing (P= 0.0641; Fig. 7A). In the 
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social choice paradigm, male CtcfNestinhet mice spent only marginally more time with the 
stranger mouse than with the object, as indicated by a significantly lower sociability 
index compared to control male siblings (P= 0.0284; Fig. 7D-E), Conversely, female 
CtcfNestinhet mice displayed comparable sociability to their control counterparts, indicating 
that loss of one copy of Ctcf in the brain causes a sex-specific defect in social behaviour.  
Male mice were then subjected to the resident-intruder assay. There was a number of 
mice of both genotypes that did not attack the intruder by the end of the allotted ten 
minutes (Fig. 7F).  We observed aggression in nearly double the number of CtcfNestinhet 
mice compared with controls, however this was not statistically significant by Fisher’s 
exact test (P= 0.1156). We also compared the latency to attack, by Student’s t-test. We 
found no significant difference in latency to attack by genotype when including the non-
attackers (P= 0.0614), and when comparing only the aggressive mice (P= 0.2712), 
although the latter comparison was under-powered.  The relative body weight of the 
resident mouse compared to the intruder can influence the resident-intruder assay, in that 
smaller size dampens aggressive behaviour23. Since the CtcfNestinhet mice are significantly 
smaller than control mice, we wanted to control for the weight difference between 
intruder and resident mice, denoted hereon as ∆size. On average, there was no difference 
in weight between any groups (Fig. S3A), and the ∆size for controls was not correlated 
with aggression (r2= 0.1399; P= 0.2330, Fig. 7G). However we found there was a 
significant association between the ∆size of CtcfNestinhet and aggressive behaviour (P= 
0.0087), and this effect was in the opposite direction than expected; smaller CtcfNestinhet 
mice were more likely to be aggressive with larger intruders (Fig. 7H). The interaction 
between ∆size and genotype was significantly associated with aggression (P=0.004). 
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Importantly, the weight of CtcfNestinhet mice was not correlated with aggression (P= 
0.8937; Fig. S3B), suggesting the observed effect is not due to smaller CtcfNestinhet mice 
being more aggressive but instead due to their relative weight to the intruder. 
3.4 Discussion 
Here we explore the role of CTCF in brain development and function using mice. The 
NestinCre driver of deletion targets Ctcf in neuroprogenitors at one allele, complementing 
previous work by others16–18.  In summary, CtcfNestinhet mice had altered volumes in the 
limbic system and cerebellum, and were hyperactive with delayed spatial learning. 
NestinCre mice, tested by others24, had no difference from control with regards to spatial 
learning and memory in multiple maze paradigms, locomotor activity in the open field, 
and acoustic startle response. This suggests our findings can be attributed to loss of a 
single copy of Ctcf in neuroprogenitors. In addition to these altered behaviours, male 
CtcfNestinhet have reduced anxiety, altered sociability, and are more aggressive than control 
siblings when presented with a larger opponent. This is in contrast to NestinCre male 
mice, which were reported to have increased anxiety, compared with controls24.   
The reduction of CTCF protein by only 25-30% embryonically in Ctcf Nestinhet mice is 
suggestive of a compensation mechanism through up-regulation of expression from the 
remaining allele. This suggests that CTCF levels are tightly regulated in the brain. This 
phenomenon has been observed in other mouse models, such as the Nipbl +/− mouse, a 
model of CdLS25,26. Approximately 40% of reported CdLS cases are attributed to 
heterozygous mutations in the NIPBL gene, which encodes the protein that loads the 
cohesin complex onto DNA27. The transcript level of Nipbl in Nipbl +/− mice was only 
reduced by 25-30% in embryonic brain and liver, however these mice still had multiple 
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severe organ and growth defects. Similar allelic compensation was observed in patients 
with CdLS, with levels depending on the type of mutation in NIPBL25,28,29. These studies 
of NIPBL, along with our findings, suggest that even small changes in the dose of 
chromatin organizer proteins are likely to affect chromatin looping and gene expression, 
and that if these occur during development, they can have drastic consequences in the 
adult. 
MRI of the CtcfNestinhet mouse brain revealed changes in total volume, as well as 
specialized regions including the anterior commissure, deep cerebellar nuclei, and the 
dentate gyrus of the hippocampus. These defects could explain many of the behaviours 
observed in our mice, or in human patients with CTCF mutations. Volumetric MRI 
performed by another group on NestinCre (Tubb5E401K/+; NestinCre+) mouse brains 
compared to control (Tubb5E401K/+) showed similar total reduced brain volume, 
suggesting that the microcephaly of CtcfNestinhet mice is due to NestinCre expression30.   
Although the cerebellum has been traditionally associated with balance, motor control 
and motor learning, it now has well-established roles in higher cognitive functions and 
has been implicated in cognitive dysmetria (difficulty in processing, prioritizing and 
responding to information) observed in schizophrenia31–34. In addition, functional MRI 
has demonstrated cerebellar activity during the processing of emotional facial 
expressions35,36, which has implications to both ASD and schizophrenia. Theory-of-mind 
tasks have also noted functional hypoconnectivity in ASD between medial cortex and 
cerebellum37. We did not see any aberrant murine behaviours traditionally associated 
with the cerebellum, such as impairment on the rotarod38,39. Typically, although motor 
learning is affected, motor training is possible on the rotarod even in cerebellum-lesioned 
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mice where there is massive degeneration of cerebellar Purkinje cells and 20% reduction 
of deep nuclei cell numbers39. Therefore, it is likely that the cerebellum changes in 
CtcfNestinhet mice, which consist predominantly of deep nuclei volume loss, are not 
sufficient to cause detectable deficits in this task.  
The CtcfNestinhet mice had evidence of impaired hippocampal function, including defects in 
traditional hippocampal-dependent tasks such as impaired learning in the Morris Water 
Maze38,40–42, and hyperactivity in the open field paradigm, which has been observed in 
hippocampus-lesioned mice38,41–43. This suggests a role for CTCF in the hippocampus 
and corroborates previous report from others which find down-regulation of CTCF in the 
hippocampus impairs acquisition and retention in the MWM18. Further, our data suggests 
that even small reductions in CTCF protein can impact spatial learning. Of interest, 
damage to the dentate nuclei bilaterally in rats impairs spatial learning in the MWM, 
without causing defect in probe trials44, which is consistent with what is observed in 
CtcfNestinhet mice in terms of behaviour. The increase in volume of the hippocampal 
dentate gyri in CtcfNestinhet mice is interesting, and further study of the role of CTCF in 
this region is warranted.  
Findings in the CtcfNestinhet mice are also suggestive of hypoconnectivity, as we observed 
reductions in volume of multiple white matter tracts including the anterior and posterior 
commissures, and the corpus callosum.  There is evidence from mouse models 
implicating corpus callosum defects in ASD-like behaviour45. There is evidence for both 
under and over connectivity in ASD, particularly in regards to cortico-cortical regions 
and interhemispheric connections46,47. In addition, reduced functional connectivity in the 
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cortex has also been correlated with auditory hallucinations and impaired cognition in 
schizophrenia48,49.  
Social behaviour has not been previously compared between NestinCre transgene-
carrying mice and controls. We found male CtcfNestinhet mice to have decreased sociability 
in the three-chamber social choice paradigm, which is found in mouse models of ASD50–
55. We did not find any evidence of increased repetitive behaviour in male CtcfNestinhet 
mice, another ASD-associated behaviour. We did find that there was an effect of size 
difference of CtcfNestinhet males and intruders with aggression, such that when the 
CtcfNestinhet mouse was smaller than the intruder, there was a decreased latency to attack. 
To our knowledge, such a phenomenon has not been previously reported in the literature. 
In fact, based on another study23, we had expected the smaller size of CtcfNestinhet mice to 
dampen aggression.  We interpret this effect on aggression as an altered perception of 
danger or altered salience. In schizophrenia, altered catecholamine signaling results in 
impaired salience and responsiveness to environmental danger cues, resulting in hyper-
arousability56–59. In support of this, we observed increased startle reflex in both sexes, 
albeit this was not statistically significant. Changes in habituation and startle reflex are 
often attributed to aberrant salience58,59, however, we did not observe any difference in 
habituation in the open field test. Therefore, further testing and replication are required 
before interpretation of this finding.  
Sex-specific behavioural differences were found in CtcfNestinhet mice. Namely, males had 
decreased anxiety and sociability compared with littermate controls. We also note that the 
traits of locomotor hyperactivity and spatial learning delay in MWM appear more 
pronounced in males, although sex was not a statistically significant co-variable. Our 
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findings are consistent with others who have found that male mice tend to be more 
sensitive to neurological perturbation and have more robust impairments60,61, which is a 
reason why female mice are often neglected from behavioural and neurobiological 
studies (reviewed in 62). Both schizophrenia and ASD have higher incidence in males63,64.  
Estrogen has been suggested as having protective effects on the brain65, particularly from 
neurodevelopmental insults, through its influence on gene expression and cell excitability 
(the protective effects of estrogen with regards to schizophrenia and ASD are reviewed in 
66). As it relates to CTCF, males and females with syndrome-causing mutations in the 
CTCF gene have been identified at similar rates4,5,7. As for the association of CTCF with 
schizophrenia, it remains unclear how the gene levels or function may be affected, and 
whether the association was stronger in males than females6. CtcfNestinhet mice share 
behavioural deficits with mice heterozygous for Bcl11a, which functions in the Baf 
swi/snf chromatin-remodelling complex, suggesting there may be shared gene expression 
changes67.  
In summary we present a model of CTCF loss in which one copy of the gene is deleted in 
neuroprogenitors, providing insight into the human syndrome resulting from CTCF 
haploinsufficiency. We present evidence for anatomical changes in the brain of 
CtcfNestinhet, specifically loss of volume in deep cerebellar nuclei, increased volume of the 
anterior cerebellar lobules, and limbic structure changes. Finally, we describe the 
behavioural changes in CtcfNestinhet mice, which include some sex-specific findings. 
Future studies will attempt to identify the molecular underpinnings of these anatomical 
and behavioural changes with CTCF loss. 
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Figure 24: CtcfNestinCre mice display sex differences in hyperactivity and anxiety. 
Figure S1. CtcfNestinCre mice display sex differences in hyperactivity and anxiety. For 
all graphs, error bars represented SEM and horizontal bar represents the mean. Distance 
travelled by (A) male and (B) female CtcfNestinCre (het) and sibling controls (ctrl) in the 
open field test, totalled across 24 five-minute intervals, analyzed by repeated-measures 
ANOVA. (C) Time spent in the centre of open field enclosure by female CtcfNestinCre (het) 
and controls (ctrl), totalled across the same 24 five-minute intervals, analyzed by 
repeated-measures ANOVA. (D) Time spent in closed and open arms of the elevated plus 
maze, analyzed by Student’s t-test. (D) Average number of arm entries in the elevated 
plus maze. (E) Average distance travelled in the elevated plus maze.      
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Figure 25: CtcfNestinCre mice have normal reversal and motor learning 
Figure S2. CtcfNestinCre mice have normal reversal and motor learning. For all graphs, 
error bars represent SEM. (A-B) Latency to target platform in MWM of CtcfNestinCre (het) 
and controls (ctrl) over four training days, then two additional training days with a new 
platform location (reversal). Comparison of first four training days is shown elsewhere 
(Fig. 5). Repeated-measures ANOVA across reversal training days was not significantly 
different between genotypes for females (A), or for males (B). (C) Average swimming 
speed from MWM day 2, grouped by sex. Genotypes were compared with Student’s t-
test. (D-E) Latency to fall from accelerating rotating rod, across 10 trials on day 1, and 4 
additional trials on day 2 for females (D), and  males (E). Repeated-measures ANOVA 
was used to compare latencies across trials, a measure of motor learning, between 
genotypes.  
 
Figure 26: Smaller size of CtcfNestinCre is not correlated with aggression. 
Figure S3. Smaller size of CtcfNestinCre is not correlated with aggression. (A) Weight of 
animals participating in the resident-intruder paradigm. The horizontal bar represents the 
mean of each group, which was compared by ANOVA. (B) Correlation between weight 
of resident- CtcfNestinCre and latency to attack. Regression line is plotted with 
corresponding equation and correlation coefficient (r2). 
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3.5 Methods 
Mouse husbandry and breeding 
Mice were maintained on a 12 hour light/ dark cycle with water and chow ad libitum. 
Behaviours were tested during the light cycle, when mice reached 3 months of age. Mice 
were group-housed with littermates, 2-5 animals per cage, and tester was blinded to 
genotype. Cages were changed once every 1-2 weeks depending on the number of mice 
per cage, and not disturbed prior to behavioural testing. Animals were handled according 
to protocols in accordance with the regulations of the Animals for Research Act of the 
province of Ontario, and approved by the University of Western Ontario Animal Care 
and Use Committee (2008-041-02).  
All mice tested were from the C57BL/6J strain. The NestinCre driver line has been 
described previously68; as have been CtcfloxP mice69. Briefly, the Nestin regulatory 
element drives CRE-recombinase expression in neuroprogenitors, beginning at 
approximately E11. Homozygous CtcfloxP mice were mated with mice carrying the 
NestinCre gene to generate male and female CtcfNestinhet mice and littermate controls. 
Embryos for brain dissection were generated in the same way by timed mating, described 
in16. To generate the four genotypes for weighing and examination of hind-limb clasping, 
CtcfNestinhet mice were mated with mice heterozygous for CtcfloxP.   
Brain dissection 
Embryos from time-mated dams were dissected at E14.5 or E16.5 on ice, and brains 
removed. Telencephalon, midbrain and hindbrain were separated then frozen on dry ice 
and stored at -80˚C for later mRNA and protein extraction.  For adult tissue, mice were 
135 
 
killed after behavioural testing by CO2 asphyxiation and brain harvested on ice. The 
cortices, hippocampi and cerebellum were dissected and frozen to be used later for 
mRNA or protein extraction.  
RT-qPCR 
Total RNA was extracted with Qiagen RNeasy Mini kit and cDNA synthesis was 
performed as previously described16 using SuperScriptTM II Reverse Transcriptase from 
Invitrogen. PCR was amplified with iQ SYBR Green supermix (Bio-Rad) using 
previously described protocols and primers16.    
Western blot analysis 
Total protein was extracted from fresh frozen tissue, using standard protocol with RIPA 
buffer. After quantification by Bradford assay, protein lysates were resolved on an 8% 
SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. Anti-CTCF 
(1:1000; Cell signalling) and anti-β-ACTIN (1:7000; Sigma Alderich) were used for 
primary detection, followed by the appropriate horseradish peroxidase-conjugated 
secondary antibodies (1:4000; GE Healthcare Life Sciences). Protein was quantified 
using ImageJ software (version 1.47).  
Brain perfusion for MRI and imaging 
Mice were killed by CO2 asphyxiation then perfused through the left ventricle of the heart 
with 30 mL of PBS (containing 1 µL/ mL heparin and 2mM ProHance) at a rate of 1.0 
mL/ min. Then 30 mL of 4% PFA + 2 mM ProHance fixation was passed at same rate. 
After perfusion, the brain was left in the skull, but the zygomatic bones, eyes, and lower 
jaw were removed. The specimen was then placed in 20 mL of 4% PFA + 2 mM 
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ProHance overnight at 4˚C. The next day, the specimen was transferred into PBS + 
0.02% sodium azide + 2 mM ProHance for storage.   
Behavioural testing 
From weaning age (21 days), mice were weighed and hind-limb clasping was measured 
on a weekly basis by a scorer who was blinded to genotype. Briefly, mice were 
suspended by the tail and lowered gently toward a solid flat surface. Wildtype mice, 
when suspended by the tail and descended towards a surface, will splay their limbs in 
anticipation of making contact, and this response was scored as non-clasping/ normal (0). 
Intermittent flexion in one or both limbs upon lowering was scored as 1, and frank 
clasping of hindlimb paws was scored as 2. Mice were considered as positive for clasping 
(score of 1 or 2) once the mouse showed clasping on at least three occasions.     
Mouse cages were randomized to cohorts, and were tested in progressively demanding 
behavioural paradigms. Mice were tested in only one paradigm per day. Cohorts were 
assigned to one of two behavioural routines A) open-field, elevated plus maze, Y-maze, 
rotating rod, and MWM with probe trials, resident-intruder, and B) marble dig, social 
approach, social choice, MWM with reversal, and acoustic startle/ prepulse inhibition.  
Open field was tested in low light conditions in a chamber 20 cm by 20 cm in size. Prior 
to starting, mice were acclimated to the room for 10 minutes. Mice were tracked using 
the AccuScan Instrument, and locomotor measures calculated over 5 minute intervals for 
two hours. To measure height-induced anxiety, we used the elevated plus maze in high 
light conditions. The total time spent in the open and closed arms was recorded over 5 
minutes by the AnyMaze software. Spontaneous alteration was measured in the three-
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armed Y-maze. Mice were tracked using the AnyMaze software and an alternation was 
recorded when a mouse entered the three different arms without re-visiting a previous 
one.  
To test motor learning, mice were placed on a rotating rod (Rotarod, San Diego 
Instruments), which was accelerated from a minimum speed of 5 to a maximum speed of 
35 rpm, by 7.0 rpm per minute. Latency to fall was measured for 14 trials, 10 performed 
on the first day, and 4 performed on the 2nd day. Inter-trial duration on the same day was 
approximately 10 minutes, during which mice were placed in their home cage.    
The MWM is a test of spatial learning and memory (reviewed in70). The MWM test was 
conducted in a 1.5 m diameter pool with 25˚C water, in dim lighting. Black and white 
shapes were placed on the walls of the room as spatial cues to find the platform which 
was submerged 0.5 cm beneath the water surface. Mice underwent 4 training sessions per 
day, each from different release points, for 4 days. The trial ended when the mouse found 
the platform. The maximum length per trial was 90 seconds, after which the mouse was 
gently guided to the platform and immobilized there for 10 seconds. The length of the 
four sessions was averaged per day and termed ‘latency to platform’. On the fifth day, 
mice underwent one probe trial lasting 60 seconds, in which the platform had been 
removed from the water. The total time spent in each quadrant was recorded using the 
AnyMaze software. Then, mice undergoing long-term spatial memory testing were 
housed for days 6-11 and underwent another probe trial on day 12. For mice undergoing 
the MWM-reversal paradigm, the platform was repositioned to the opposite quadrant and 
mice underwent four sessions per day on day 6 and 7.      
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Acoustic startle was measured as previously described71. Mice were placed in the 
chamber with background noise (65 db) for five minutes on days 1 and 2, to acclimatize 
the mice to the apparatus (SR-LAB, San Diego Instruments). On day 3, mice again were 
acclimated for 10 minutes with background noise and then underwent a habituation 
block, consisting of fifty acoustic startle trials, with 20 ms stimulus of 115 db, and 
intertrial interval of 20 seconds. After the habituation block, the mice underwent a 
prepulse-inhibition block consisting of ten sets of five types of trials randomly ordered 
with variable intertrial intervals of 10, 15, or 20 seconds. Four of the five trial types 
consisted of prepulses (intensity of 75 or 80 db, length of 20 ms), separated from the 
startle stimulus (intensity of 115 db, length of 40 ms) by an interstimulus interval of 
either 30 ms or 100 ms. The fifth trial type was a startle pulse alone. The startle response 
was measured by the mouse’s movement on the platform, which generates a transient 
force analyzed by the software. The startle magnitude was an average for the ten trials of 
each trial type.      
Marble burying was tested as previously described by others74. The marble burying assay 
was conducted under dim lighting conditions in a 32 x 43 cm cage was filled with 4 cm 
of corncob bedding with 25 evenly-spaced marbles. Mice were left in the cage for 30 
minutes, after which the total number of buried marbles (>3/4 surface covered) were 
recorded.  
For the social approach paradigm, mice underwent 2 days of habituation to a neutral 
cage, before being placed with a stranger conspecific, same-genotype mouse on the third 
day for 10 minutes. Among the male mice, we found there was one outlier among the 
controls which we excluded from the analysis. Time spent interacting (sniffing the other 
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mouse), as well as time spent grooming and digging, was recorded for the test mouse by 
an observer blinded to genotype.     
The three chamber social choice test was set up as follows: two chambers containing a 
cylindrical enclosure, separated by a middle neutral chamber. The test mouse was 
allowed to move freely between the three chambers during a 10 minute habituation phase, 
after which a conspecific wildtype stranger mouse was placed in one of the cylindrical 
enclosures, and a novel object was placed in the other. The test mouse was again allowed 
to explore the apparatus for 10 minutes, during which the time spent in the “novel object” 
and “stranger mouse” chambers were measured. To calculate sociability index, the time 
spent with the stranger mouse was divided by the sum of time spent with stranger mouse 
and novel object. 
Aggression was tested using the resident-intruder paradigm60 in male mice (typically 
female mice are insufficiently aggressive for testing). Male mice were housed alone for 
21 days and then a group-housed, same age (4-month), wildtype male (intruder) was 
placed in the test mouse’s cage (resident). Mice were observed closely for up to 10 
minutes in order to stop the test if the resident mouse attacked. Attack latency was 
recorded. There was no instance of an intruder mouse attacking the resident mouse. 
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Chapter 4 
4 Discussion 
4.1 4.1 General overview 
ID, ASD and SCZ are heterogeneous disorders with related etiology. Gene-mutation of 
factors regulating chromatin architecture can cause these disorders, indicating this 
mechanism of regulation is of particular importance to brain development. CTCF is a 
ubiquitous chromatin-organizing protein that mainly regulates gene expression through 
chromatin looping. Mutations in one copy of the CTCF gene were found to cause ID and 
ASD, and CTCF has also been associated with SCZ, demonstrating the important role for 
this factor in neurodevelopment. Despite this, there have been only a handful of studies 
investigating the function of CTCF in the brain.  
The goal of this study was to investigate the role of CTCF in early brain development and 
potential consequences in the postnatal brain. Conditional whole-brain and MGE-specific 
Ctcf knockout mouse models were generated using the NestinCre and Nkx2.1Cre driver 
lines, respectively. This is the first study to show that CTCF is an important upstream 
regulator of cortical interneuron fate specification, which is highly relevant to disease, 
given that dysfunction of these neurons has been reported in ID, ASD, and SCZ. I also 
provide insight into the transcriptional dysregulation that mechanistically links altered 
chromatin higher order structure and neurodevelopmental disorders. In the second arm of 
this study, the outcome of Ctcf heterozygosity was examined in the mouse brain, which 
uniquely models the human ID syndrome. I characterized the behaviour and brain 
structure of these Ctcf-deficient mice, which phenotypically resemble those of other 
mouse models of ID, ASD and SCZ.   
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4.2 The role of CTCF in MGE development 
The deletion of Ctcf from the developing brain using the NestinCre driver line resulted in 
reduced expression of genes with ontology implicated in interneuron development. By 
deleting Ctcf specifically from the MGE using the Nkx2.1Cre driver, I create an elegant 
model in which we could explore the cell-autonomous effects of Ctcf loss from this 
region. In addition, as these conditional Ctcf mutants survive into the postnatal period, 
this allowed us to study the outcome of Ctcf loss on the final laminar position and 
subtype specification of the cortical interneurons.     
As with whole-brain loss of Ctcf, the deletion of Ctcf from the MGE led to decreased 
expression of Lhx6. As the LHX6 transcription factor has been well-established as 
required for the generation of PV and SST cortical interneurons, it is unsurprising that we 
saw a corresponding decrease in the numbers of these interneuron subtypes in the P21 
Ctcf conditional mutant. We also saw a decrease in the number of MGE-derived 
migrating cortical interneurons during development (E16.5), but by P21, there are a 
similar number of GABAergic cells in the cortex of the Ctcf conditional mutant. This is 
most likely explained by a combination of two things: i) Lhx6 is known for regulating 
multiple factors involved in migration, so migration is impaired or inefficient, and ii) the 
MGE-derived cells partially adopt the default fate of CGE-derived interneurons, which 
are known to migrate later into the developing cortex. In support of this second 
explanation, the interneurons occupied more superficial laminar positions consistent with 
CGE-derived interneuron behaviour. Defaulting to a CGE-derived fate is closely linked 
to LHX6 function; interneurons from Lhx6 and Nkx2.1 mutants have been shown to not 
only occupy superficial laminar layers, but also to have CGE-like morphology, 
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electrophysiology, and express CGE markers1,2. Together, this shows that CTCF is an 
important regulator of the transcriptional pathway that allows deviation from the default 
CGE-derived interneuron fate in order to generate MGE-derived PV and SST 
interneurons.  
Transduction of Lhx6 into Ctcf-null MGE cells was sufficient to rescue MGE-like 
laminar position and interneuron subtype, suggesting CTCF functions upstream of LHX6 
in the MGE. Expression of NKX2.1 was unperturbed in the Ctcf-null brains, and we did 
not find any evidence of interaction between NKX2.1 and CTCF. One possibility is that 
in the absence of CTCF, chromatin architecture is not permissive for NKX2.1 binding at 
LHX6. Additional studies will be required to precisely uncover how CTCF affects 
chromatin structure and gene expression in the MGE. 
I found that CTCF not only controls MGE versus CGE fate of cortical interneurons. 
When I deleted CTCF from the developing MGE, there was a concomitant increase in 
Lhx8, which encodes a transcription factor with shared and distinct functions from LHX6. 
LHX8 overlaps with LHX6 in some of its down-stream effectors, as demonstrated by the 
partial rescue of PV and SST interneuron numbers with Lhx8 transduction into Lhx6-
mutant MGE cells2. So one possibility is that Lhx8 becomes over-activated as part of a 
compensatory mechanism with the loss of Lhx6 in the Ctcf mutant MGE. However, re-
expression of Lhx6 did not normalize the level of Lhx8 transcript, suggesting that Lhx8 is 
regulated separately by CTCF.  
I showed that CTCF regulates the dichotomy between Lhx6 and Lhx8 expression, but the 
mechanistic link between CTCF, Lhx6 and Lhx8 remains unknown. I found CTCF 
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binding at the Lhx8 gene. A few remaining questions are whether CTCF binds at the Lhx8 
gene to place it in a repressive loop in certain cells, and whether over-expression of Lhx8 
causes decreased Lhx6 expression, as LIM proteins are known to regulate each other. It is 
possible that deregulation of Lhx8 with loss of CTCF may be the upstream cause of Lhx6 
inactivation. Since GABAergic striatal neurons co-express Lhx6 and Lhx8, it is unlikely 
that LHX8 would directly inhibit Lhx6, but may act through another factor. There are no 
models of LHX8 over-expression reported in the literature. It would be interesting to 
further characterize the consequences of its over-expression, namely whether the 
increased number of basal forebrain projection neurons persists post-natally. 
I observed an increase in the number of basal forebrain projection neurons, suggesting 
that the imbalance between Lhx6 and Lhx8 in the Ctcf-null MGE results in some MGE 
cells becoming re-specified to basal forebrain projection neurons. This likely occurs at 
the expense of cortical interneurons, however as the total number of basal forebrain 
projection neurons represents a small population, even large increases in the numbers of 
these cells is not likely to be sufficient to significantly impact the total number of cortical 
interneurons by our quantification methods, representing a limitation of the current 
model.       
Future studies in the MGE may examine how a decreased amount of CTCF may alter 
chromatin organization, or make its three dimensional structure less stable, and more 
vulnerable to secondary environmental or genetic insults. The idea that the developmental 
cascade specifying the MGE may be more vulnerable to stressors is easy to reconcile 
with the hypothesis that it is a deviation from the default transcriptional profile which 
would specify CGE fate. There have been a few reports investigating the transcriptional 
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profiles of MGE cells, with the goal of understanding the large diversity of cells 
generated in this transient organ3,4. Future studies may compare CGE and MGE 
transcriptional profiles and chromatin organization. 
4.3 Implications to disease treatment 
There has been interest in using GABAergic interneurons as a cell-based therapy in 
human neurologic disease21. Studies in mice show that upon transplantation into a mature 
host brain, GABAergic interneurons retain the ability to laminate into appropriate layers 
and functionally integrate into circuits22,23. In models of epilepsy, the transplantation of 
MGE progenitors into the mature hippocampus or visual cortex reduced seizure 
frequency and severity about 3-4 weeks after surgery24–26 and these benefits persisted 
even 6 months after transplantation24. Given that cortical interneuron dysfunction and 
imbalances in excitation-inhibition are implicated in ID, SCZ, and ASD (section 1.3.5), 
there has been a great momentum to understand how to differentiate these cells in vitro 
from pluripotent cells. Understanding the development of the transplanted cells is 
required to prevent possible inappropriate differentiation, proliferation or migration of 
grafts. Our results designate CTCF as a novel regulator of interneuron genesis, and 
therefore can contribute to future efforts to improve the in vitro generation of 
interneurons from stem cells. 
Recently, protocols were developed for deriving functionally mature cortical interneurons 
from human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells 
(hESCs) 27,28. In addition to potential use as grafts, development of cortical interneurons 
from hiPSCs or hESCs permits the generation of large homogeneous populations of cells 
that can be used for modeling neurological disorders and testing novel drugs in vitro29. 
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One difficulty with deriving cortical interneurons is the lengthy maturation time the cells 
must undergo29. Optimizing levels of CTCF protein levels may be used to push MGE-
derived cells down a desired lineage, and may help decrease human interneuron 
maturation times by more quickly inducing chromatin conformations required for 
specifying interneuron cell fate. 
4.4 Limitations of study of CTCF in MGE 
It has been difficult to study the role of CTCF in gene regulation because its deletion 
causes cell death in so many tissues. We circumvented cell death in the NestinCre-
mediated Ctcf knockout embryos by concomitant deletion of Puma, but these mice still 
died at birth. Mice survived longer with the loss of Ctcf from the MGE, but eventually 
succumbed to hypothyroidism, likely due to Nkx2.1Cre expression in the thyroid. We 
presume that CTCF deletion from the thyroid results in extensive cell death, as with other 
tissues11,70,71. This limited our study of these mice to weaning age. The adult pattern of 
cortical interneuron laminar positioning is well established by this time-point, but 
networks are not fully matured until about P302, therefore we could not test the 
functionality of Ctcf-null cortical interneurons. In future studies, this limitation could be 
overcome by testing transplanted Ctcf-null MGE cells in wildtype mouse brain, by 
performing in utero electroporation of the MGE with Ctcf shRNA, or by treating 
Nkx2.1Cre Ctcf-null mice with thyroxine.        
4.5 Validity of the CtcfNestinhet mice as a model of the associated human syndrome and SCZ 
There are several well-established rodent models of SCZ that have allowed the 
establishment of the murine behaviours which best represent symptoms of SCZ including 
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1) spontaneous locomotor hyperactivity, which is thought to emulate the delusions/ 
hallucinations seen in humans; 2) sensorimotor gating deficits; 3) reduced re-learning, 
which represents cognitive inflexibility or impairment; 4) Deficits in social interaction.  
A similar constellation of behaviours contributes to the face validity of ASD mouse 
models to the human disorder, including social deficits and repetitive behaviours30. 
Additional associated behaviours are often present, and can include cognitive 
inflexibility, anxiety, hyperactivity, and altered sensory reactivity.   
Table 1 summarizes the behavioural differences identified in CtcfNestinhet mice. CtcfNestinhet 
mice have hyperactivity and impaired spatial learning. In addition, male CtcfNestinhet mice 
had decreased anxiety and altered social behaviour. Spontaneous locomotor hyperactivity 
is often seen in SCZ mouse models (section 1.4.1). Impaired spatial learning is typically 
associated with mouse models of ID, and decreased sociability is phenotypic of ASD and 
SCZ models (section 1.4.1). Therefore CtcfNestinhet mice do show face validity to the 
associated human syndrome. One surprise is that we did not see an increase in repetitive 
behaviours, which is robustly observed in ASD mouse models. However, not all patients 
with CTCF mutation are described as autistic, and one possibility is that stereotypies are 
not a predominant feature of the human syndrome.    
4.6 The male brain is more susceptible to neurological perturbation 
We observed more severe and additional behaviour defects in male CtcfNestinhet mice than 
females. This is consistent with others who have found that male mice tend to be more 
sensitive to neurological perturbation and have more robust impairments31,32. This is why 
female mice are commonly excluded from behavioural and neurobiological studies 
(reviewed in 33).  
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Table 4: Summary of CtcfNestinhet behaviours 
Table 1: Summary of CtcfNestinhet behaviours 
 
 
 
Both SCZ and ASD have higher incidence in males34,35. Estrogen has been suggested as 
having protective effects on the brain36, particularly from neurodevelopmental insults, 
through its influence on gene expression and cell excitability (reviewed in 37). We 
observed a sociability deficit in male CtcfNestinhet mice but not females. In SCZ, it has 
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been reported that negative symptoms (such as social withdrawal) are less severe in 
females38. In regards to the association of CTCF with SCZ, it remains unclear whether 
the association was stronger in males than females17.  Males and females with syndrome-
causing mutations in the CTCF gene have been identified at similar rates6,13,14.     
4.7 The phenotype of CtcfNestinhet mice resemble other mutant mouse models of chromatin factors 
Upon reviewing the literature, we identified other mice with a similar profiles to 
CtcfNestinhet mice, which surprisingly are implicated in chromatin regulation. CtcfNestinhet 
mice share many behavioural deficits with mice heterozygous for Bcl11a deletion, which 
functions in the Baf swi/snf chromatin-remodelling complex, suggesting there may be 
overlap in the transcriptional networks regulated by CTCF and BCL11A39. In humans, 
BCL11A gene mutation causes Dias-Logan syndrome, which has microcephaly and ID as 
core features, with 30% of patients also having ASD. Interestingly, some of the patients 
with this syndrome are reported to have cerebellar vermis hypoplasia, hypoplasia of the 
corpus callosum and decreased white matter volume39, some of which are features of the 
CtcfNestinhet mice on MRI. When normalized for brain volume, there were decreases in 
Bcl11a +/- mice in the volumes of the hippocampus (all areas except the dentate gyrus), 
corpus callosum, amygdaloid nuclei, ventral midline thalamic nuclei, and parts of the 
cerebellum, which has extensive overlap with what we observe in CtcfNestinhet mice. This 
overlap in the human syndrome, the mouse model behaviour, and the brain structure 
suggests that CTCF and BCL11A likely regulate the same transcriptional networks.     
Mutation of BCL11B, the homolog of BCL11A, also known as CTIP2, causes 
immunodeficiency and ID40, and has been implicated in postnatal development of the 
dentate gyrus41. Forebrain ablation of Bcl11b in mice using Emx1Cre resulted in a 
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reduction in granular cell number, resulting in a smaller dentate gyrus41. These mice had 
impaired spatial learning and memory, and hyperactivity. In addition, a patient with 
BCL11B mutation had agenesis of the corpus callosum (the largest white matter structure 
in the brain). In CtcfNestinhet mice, we observed decreased volumes of the anterior 
commissure, a white matter tract. but there was an increased volume in the dentate gyrus 
of the hippocampi. However it is possible that there would be more overlap of CtcfNestinhet 
mice with mice that are heterozygous for Bcl11b in the forebrain, instead of those with 
complete ablation. In support of this, complete ablation of Ctcf from the postnatal 
hippocampus causes widespread apoptosis at 14 weeks, a very different phenotype from 
that observed in CtcfNestinhet mice.    
Mice mutant for the Cbp gene, which is associated with Rubinstein-Taybi syndrome, 
have many behavioural abnormalities42, some of which overlap with CtcfNestinhet mice. 
The Cbp mutant mouse behaviours include repetitive behaviours, hyperactivity, social 
deficits, decreased anxiety, impaired nest building, increased aggression, impaired motor 
function and impaired long-term memory42. With the exception of spatial learning, which 
was not assessed in these mice, they have all the features of CtcfNestinhet male mice and 
more. Notably, mice heterozygous for p300 deletion, despite also being a model of 
Rubinstein-Taybi syndrome, do not share these same behaviours43. This suggests that like 
BCL11A, the transcriptional targets of CBP also likely overlap with those of CTCF. This 
reaffirms the newer consensus opinion about CTCF, which is that its function in 
promoting enhancer-promoter interactions is more relevant than its role as a genetic 
insulator. Future studies should compare the transcriptomes from brain-relevant samples 
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of these mutant mice. There is also a possibility that there may be cooperation between 
CBP and CTCF in gene regulation.  
4.8 Brain structure of the CtcfNestinhet mice and further evidence for the cerebellum in cognition 
MRI revealed volume changes in multiple limbic structures of the CtcfNestinhet brain. 
These structures may be involved in emotional processing and social functioning. We 
also measured a decrease in the volumes of the deep cerebellar nuclei, and an increase in 
the anterior lobe of the cerebellum. Although traditionally associated with balance, motor 
control and motor learning, the cerebellum now has an emerging role in cognition; the 
same processing that allows for the cerebellum to automate motor tasks is relevant to 
automating thoughts and implicit cognitive processes47.  
The cerebellum regulates the rest of the brain though the cerebello-thalamo-cortical 
pathway, and defects in this circuit at both the cerebellum and thalamus have been 
implicated in the cognitive dysmetria (difficulty in processing, prioritizing and 
responding to information) observed in SCZ48–51. Liu et al 48 found evidence for damage 
to cerebellum itself in 10 schizophrenia patients compared to controls. In ASD, deficits in 
the ability to implicitly process non-verbal and social cues may be related to cerebellar 
defects, as functional MRI has demonstrated cerebellar activity during the processing of 
emotional facial expressions52,53. Links between ASD and the cerebellum have been 
reviewed extensively, and include altered cerebellar volumes and Purkinje cell numbers 
in subjects ASD compared to controls 47,54,55. Theory-of-mind tasks have noted functional 
hypoconnectivity in ASD between medial cortex and cerebellum56.  In addition, 
individuals with ASD do not activate the left cerebellum like controls, when implicitly 
processing emotional facial expressions57. 
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An ASD mouse model in which Tsc1 is deleted from cerebellar Purkinje cells leads to 
abnormal social interaction, impaired MWM reversal, and repetitive behaviour58. 
Cerebellum-lesioned mice have increased latencies to target in MWM, and this has been 
correlated with size of the lesion59. Cerebellum-lesioned rodents show tapered reductions 
in latency to target platform compared to control, reminiscent to CtcfNestinhet mice, and 
show no or mild defects in target location memory retention59–63. Specific lesion of the 
cerebellar dentate nuclei bilaterally in rats can cause this spatial learning deficit pattern62. 
Thus the pattern of learning deficit observed CtcfNestinhet mice may be more consistent 
with impairments in cerebellar function than with that of hippocampus59,64,65. This likely 
reflects a role for the dentate nuclei in the cognitive processes in MWM acquisition, 
without affecting memory retention.  
I observed increases in the volume of the hippocampal dentate gyrus in the CtcfNestinhet 
mice. This could be caused by an increase in grey matter in this region, but will require 
further elucidation in the future. It may represent a compensation for having impaired 
spatial learning due to cerebellar defects, as increased grey matter volumes in the 
hippocampus have been associated with improved spatial sense66. Alternatively, 
increased dentate gyrus volume may result from altered densities of cell subpopulations 
as a direct result of decreased CTCF.    
4.9 Future investigation of GABAergic neurons in CtcfNestinhet mice 
Despite the role for Ctcf in the development of interneurons, we did not investigate the 
numbers and positioning of cortical interneurons in the Ctcf haploinsufficiency model, 
which may provide relevant insight into the mechanistic links of CTCF to human ID, 
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ASD and SCZ. We expect that cortical interneuron development and/ or function is 
abnormal with loss of one functional copy of Ctcf.  
It would also be interesting to determine whether there is an increase in the number of 
GABAergic basal forebrain projection neurons in the Ctcf haploinsufficiency model.  
Clinical and animal studies have linked the basal forebrain with abnormal aggression 
(reviewed in 67). In addition, the valence of aggressive behaviour in the resident-intruder 
paradigm has been linked to GABAergic projection neurons from the basal forebrain to 
the lateral habenula68. It is possible that the abnormal aggression observed in the 
CtcfNestinhet mice is related to an increased number of GABAergic basal forebrain 
projection neurons. In addition, rats with higher numbers of basal forebrain GABAergic 
projection neurons perform worse on spatial learning tasks69, an impairment we observed 
in the CtcfNestinhet mice.   
4.10 Limitation of the Ctcf haploinsufficiency mouse model  
Our study of mice heterozygous for Ctcf in the brain was complicated by effects of the 
NestinCre transgene. The NestinCre driver mice have mild hypopituitarism and postnatal 
growth retardation, due to insertion of the human growth hormone gene with the 
NestinCre, which down-regulates the mouse growth hormone gene and causes decreased 
levels of Igf-172.  Male NestinCre mouse behaviour is grossly normal, but it has been 
reported that the NestinCre mice spend less time freezing in contextual and cued fear 
conditioning paradigms73. The NestinCre mice also spent significantly less time in the 
open arms of the elevated plus maze, suggesting the decreased freezing time is not due to 
decreased anxiety, but due to impaired fear memory acquisition. Of note, spatial memory 
acquisition was not significantly different in NestinCre mice. In addition, mice with 
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increased hypothalamic growth hormone receptor signaling, like NestinCre mice, 
typically have reduced anxiety, which is inconsistent with the findings of Giusti et al 73. 
Therefore, it is difficult to reconcile these and our findings.  
Despite having grossly normal behaviour, in our study we observed increased hind-limb 
clasping due to the NestinCre transgene, which suggests neurological function is 
abnormal. Due to previous extensive behavioural phenotyping of the NestinCre mice, we 
did not use them as a behavioural control in our study, which in hindsight may limit the 
interpretation of some of the findings. We also did not use the NestinCre mice as a 
control for the structural MRI study, which is another limitation. Others have reported 
that NestinCre mice have reduced brain volumes similar to our Ctcf haploinsufficiency 
model but no other brain structure abnormalities were reported74.  
4.11 Implications 
De novo, disrupting mutations in regulators of chromatin architecture are frequent causes 
of  ASD and severe ID5–7, suggesting that chromatin structure is an important regulatory 
mechanism of gene expression particularly in the brain. CdLS and Mediator-related 
syndromes were described as “transcriptomopathies”8,9, that is a disease caused by global 
alteration of gene expression. As these complexes are also involved in chromatin looping, 
the syndromes caused by CTCF mutations likely have altered transcriptome as a shared 
etiology (reviewed in 10). Although the ASD/ ID syndromes caused by mutation of the 
individual genes are distinct, there are multiple shared features and the commonly 
affected molecular pathways remain poorly understood. Therefore, characterizing the 
transcriptional pathways that are altered with CTCF loss from the brain is an important 
step in understanding this group of disorders. Previous work characterizing the 
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transcriptional pathways regulated by CTCF in the brain have implicated it in 
neuroprogenitor survival through PUMA regulation11, and neuron connectivity through 
the activation of Pcdh gene clusters12. My study advances our understanding by i) 
identifying a role for CTCF in MGE development, and ii) generating a mouse model of 
Ctcf loss with behavioural and brain structural changes congruent with CTCF-related 
disorders that can be used for further study. 
CTCF has been associated with SCZ17, which shares etiology with ASD18,19. This finding 
has not yet been replicated, but the dysregulation of interneuron development, the 
hyponnectivity, and the behaviour profile of Ctcf mutant mice in our study are consistent 
with a possible role in SCZ. It is possible that disrupting mutations of CTCF cause ASD/ 
ID whereas polymorphisms influencing small or regional/timing-specific changes in 
expression of CTCF predispose to SCZ, along with other environmental and genetic 
factors. Intriguingly, maternal immune activation (MIA), commonly utilized to generate a 
SCZ rat model, caused altered expression of genes implicated in cortical interneuron 
migration20, implying the transcriptional pathways regulating these cells may be 
particularly vulnerable.  I am the first to show that CTCF is a required upstream regulator 
in cortical interneuron development.   
I generated a mouse model of Ctcf loss that provides an opportunity to further study 
ASD, SCZ and ID. I found that early transcriptional compensation restores CTCF levels 
in the adult brain of this model system. Importantly, I observed brain structural changes 
in the cerebellum and the limbic system of the CtcfNestinhet mice, implicating these 
structures are important in these human conditions. Further, this signifies that decreased 
CTCF levels in the embryonic brain are sufficient to cause structural and behavioural 
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changes. Future studies could utilize this mouse model to characterize the abnormalities 
in the transcriptome and development of the embryonic precursors of these brain 
structures.  
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